<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><?properties manuscript?><front><journal-meta><journal-id journal-id-type="nlm-journal-id">101618821</journal-id><journal-id journal-id-type="pubmed-jr-id">41837</journal-id><journal-id journal-id-type="nlm-ta">Lancet Diabetes Endocrinol</journal-id><journal-id journal-id-type="iso-abbrev">Lancet Diabetes Endocrinol</journal-id><journal-title-group><journal-title>The lancet. Diabetes &#x00026; endocrinology</journal-title></journal-title-group><issn pub-type="ppub">2213-8587</issn><issn pub-type="epub">2213-8595</issn></journal-meta><article-meta><article-id pub-id-type="pmid">27595918</article-id><article-id pub-id-type="pmc">5094846</article-id><article-id pub-id-type="doi">10.1016/S2213-8587(16)30162-0</article-id><article-id pub-id-type="manuscript">HHSPA814901</article-id><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Association of the Magnitude of Weight Loss and Physical Fitness Change on Long-term CVD outcomes: The Look AHEAD Study</article-title></title-group><contrib-group><contrib contrib-type="author"><collab>The Look AHEAD Study Group</collab></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Gregg</surname><given-names>Edward W.</given-names></name><degrees>PhD</degrees><aff id="A1">Division of Diabetes Translation, Centers for Disease Control and Prevention, Atlanta, GA 30341</aff></contrib></contrib-group><author-notes><fn id="FN1"><label>*</label><p id="P1">Authors and Investigators in the Look AHEAD (Action for health in Diabetes) Research Group are listed in the <xref ref-type="app" rid="APP1">Appendix</xref>.</p></fn></author-notes><pub-date pub-type="nihms-submitted"><day>19</day><month>10</month><year>2016</year></pub-date><pub-date pub-type="epub"><day>30</day><month>8</month><year>2016</year></pub-date><pub-date pub-type="ppub"><month>11</month><year>2016</year></pub-date><pub-date pub-type="pmc-release"><day>01</day><month>11</month><year>2017</year></pub-date><volume>4</volume><issue>11</issue><fpage>913</fpage><lpage>921</lpage><!--elocation-id from pubmed: 10.1016/S2213-8587(16)30162-0--><permissions><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc-nd/4.0/"><license-p>This manuscript version is made available under the CC BY-NC-ND 4.0 license.</license-p></license></permissions><abstract><sec id="S1"><title>Background</title><p id="P2">The Look AHEAD Study found no significant reduction in cardiovascular disease (CVD) incidence among adults with diabetes enrolled in an intensive weight loss intervention (ILI) compared to those randomized to diabetes support and education (DSE). We examined whether CVD incidence in Look AHEAD varied by weight or fitness change.</p></sec><sec id="S2"><title>Methods</title><p id="P3">Among overweight or obese adults people aged 45&#x02013;76 with type 2 diabetes in the Look AHEAD study, this observational analysis examined the association of magnitude of weight loss (N=4834) and fitness change (N=4406) over the first year with CVD incidence over a median 10.2 years of follow-up. The primary outcome was a composite of CVD death, myocardial infarction, stroke, or angina hospitalization; the secondary outcome included the same indices plus coronary&#x02013;artery bypass grafting, carotid endartectomy, percutaneous coronary intervention, hospitalization for congestive heart failure, peripheral vascular disease, or total mortality. Analyses adjusted for baseline differences in weight or fitness, demographics and CVD risk factors.</p></sec><sec id="S3"><title>Findings</title><p id="P4">In analyses of the full cohort combining ILI and DSE, persons who lost &#x0003e; 10% body weight in the first year had 21% lower risk of the primary outcome (HR=0.79, 95% CI, 0.64 to 0.98) and a 24% reduced risk of the secondary outcome (HR=0.76, 95% CI, 0.63 to 0.91) relative to those with stable weight/weight gain. Achieving a &#x0003e; 2 MET fitness change was associated with a significant reduction in the secondary outcome (HR=0.77, 95% CI, 0.61 &#x02013; 0.96) but not the primary outcome (HR=0.78, 0.60 &#x02013; 1.03). In analyses treating the DSE as the referent group, ILI participants with &#x0003e; 10% weight losses had a 20% lower risk of the primary outcome (HR=0.80 (95% CI, 0.65 &#x02013; 0.99) and a 21% reduced risk of the secondary outcome (0.79 (95% CI, 0.66 &#x02013; 0.95); fitness change was not significantly associated with either outcome.</p></sec><sec id="S4"><title>Interpretation</title><p id="P5">This secondary analysis of Look AHEAD suggests an association between the magnitude of intentional weight loss and CVD incidence.</p></sec></abstract></article-meta></front><body><sec id="S5"><title>BACKGROUND</title><p id="P6">Observational studies have consistently associated obesity, physical inactivity, and low fitness with increased risk of cardiovascular disease (CVD) (<xref rid="R1" ref-type="bibr">1</xref>&#x02013;<xref rid="R3" ref-type="bibr">3</xref>). Randomized controlled trials (RCTs) have shown that lifestyle interventions to reduce weight and increase physical activity levels lead to diverse metabolic benefits, including decreased levels of insulin resistance, blood pressure, and inflammatory markers, improved lipid profiles, decreased incidence of type 2 diabetes, and among persons with diabetes, improved glycemic control (<xref rid="R4" ref-type="bibr">4</xref>&#x02013;<xref rid="R9" ref-type="bibr">9</xref>). However, whether these benefits lead to reduced CVD incidence, which remains the greatest single cause of morbidity and mortality for adults with diabetes, remains unclear. Observational studies of intentional weight loss have yielded mixed findings, ranging from modest benefit to harm (<xref rid="R10" ref-type="bibr">10</xref>). The Look AHEAD Study (Action for Health in Diabetes), the largest RCT to date of an intensive lifestyle-based weight loss intervention, led to numerous health benefits but had no significant effect on CVD morbidity and mortality (<xref rid="R9" ref-type="bibr">9</xref>, <xref rid="R11" ref-type="bibr">11</xref>&#x02013;<xref rid="R13" ref-type="bibr">13</xref>).</p><p id="P7">A variety of explanations have been offered for the lack of an effect of ILI on CVD outcomes in Look AHEAD. One possible explanation is that the weight losses achieved were not large enough to produce an impact on CVD outcomes. Behavioral responses to intensive weight loss interventions are notoriously heterogeneous, as some participants have a limited weight loss or fitness effect in the first year, and others achieve substantial changes in weight or fitness (<xref rid="R14" ref-type="bibr">14</xref>&#x02013;<xref rid="R16" ref-type="bibr">16</xref>). It is conceivable that an intensive lifestyle intervention can reduce long-term CVD incidence for people with favorable behavioral and weight loss responses, but have its benefits obscured by people who are unsuccessful at weight loss. In these secondary analyses we examine the association between the magnitude of weight loss and physical fitness from baseline to one year and CVD incidence using 2 perspectives: First, we examine the association of weight change and fitness changes to CVD incidence for the full Look AHEAD cohort, combining both participants in ILI and DSE. Second, we compare CVD rates in ILI participants according to their weight change and fitness response, with participants from the DSE group.</p></sec><sec sec-type="methods" id="S6"><title>METHODS</title><sec id="S7"><title>Study Design, Sample, and Inclusion Criteria</title><p id="P8">Look AHEAD was a multicenter, randomized controlled trial that tested the impact of an intensive lifestyle intervention on cardiovascular disease outcomes (<xref rid="R17" ref-type="bibr">17</xref>, <xref rid="R18" ref-type="bibr">18</xref>). Overweight and obese adults aged 45 to 76 years with type 2 diabetes were recruited at 16 research centers and randomized to either an ILI aimed at achieving sustained weight loss and increased physical activity or to a diabetes support and education intervention (DSE). Eligibility required a body mass index &#x0003e; 25 kg/m<sup>2</sup> or &#x0003e; 27 kg/m<sup>2</sup> among those receiving insulin therapy. Diabetes status was verified by use of diabetes medication or physician report. Participants were excluded from Look AHEAD if they had hemoglobin A1c levels &#x0003e; 11%, systolic blood pressure &#x0003e;160 mm Hg, diastolic blood pressure &#x0003e; 100 mm Hg, or plasma triglyceride levels &#x0003e; 600 mg/dl, or were unable to complete a maximal graded exercise test or two weeks of diet and activity self-monitoring. These criteria led to a sample of 5145 adults with diabetes who were randomized equally to ILI or DSE. All participants signed a consent form approved by their local institutional review board.</p></sec><sec id="S8"><title>Intervention</title><p id="P9">Details of the intensive lifestyle intervention (ILI) have been described previously (<xref rid="R18" ref-type="bibr">18</xref>, <xref rid="R19" ref-type="bibr">19</xref>). In brief, the ILI included weekly group and individual sessions in the first 6 months, followed by two group sessions and one individual session per month for the second 6 months, and two contacts per month (at least one in person) for years 2 through 4. The ILI aimed to reduce total caloric intake to 1200 to 1800 kcal/d based on initial weight and reduce total fat and saturated fat content to less than 30% and 10%, respectively, with support from calorie counting and provisions of meal replacements. Participants were counseled to achieve a goal of 175 minutes of physical activity per week, such as brisk walking. Behavioral strategies included self-monitoring, goal setting, and problem solving. Participants in the DSE were offered 3 group sessions each year focusing on diet, physical activity, and social support but individualized behavioral support was not provided and participants were not weighed during the sessions. Medical or pharmacological care for control of hyperglycemia, lipids, and blood pressure were provided by the participant&#x02019;s physician independent of the Look AHEAD study for both groups, with the exception of temporary changes in glucose-lowering medications that were made by study staff to reduce the risk of hypoglycemia in the ILI group.</p></sec><sec id="S9"><title>Assessments</title><p id="P10">Participants attended a baseline clinic visit and annual follow-up visits, during which body weight and height were assessed using a digital scale and stadiometer, respectively. A maximal graded exercise test was administered at baseline and a submaximal exercise test conducted at years 1 and 4. Changes in fitness were computed as the difference between estimated metabolic equivalents at the point that the participants achieved or exceeded 80% of age-predicted maximal heart rate or a rating of perceived exertion of at least 16 at baseline and at the subsequent assessment (<xref rid="R20" ref-type="bibr">20</xref>, <xref rid="R21" ref-type="bibr">21</xref>). Intervention response was based on the difference in weight and fitness between the baseline and first year clinic visit.</p></sec><sec id="S10"><title>Outcomes</title><p id="P11">We restricted our analyses to the Look AHEAD pre-specified outcomes, adjudicated by a masked outcomes committee. The primary CVD outcome was defined as first occurrence of non-fatal acute myocardial infarction (AMI) or stroke, hospitalized angina, or CVD death. The secondary outcome included the same indices plus coronary&#x02013;artery bypass grafting, carotid endartectomy, percutaneous coronary intervention, hospitalization for congestive heart failure, peripheral vascular disease, or total mortality. The median follow-up period was 10.2 years.</p></sec><sec id="S11"><title>Statistical Analyses</title><p id="P12">For the analyses related to weight change, we excluded 246 persons (95 from ILI and 151 from DSE) lacking body weight measurements and 65 persons who had a primary event before the first annual clinic visit, leaving an analytic sample size of 4834. (Corresponding sample size for the secondary outcome was 4813). For the analyses related to fitness, we excluded 688 persons (278 from ILI and 398 from DSE) lacking fitness measurements, and 51 persons who had a primary event before the first annual clinic visit, leaving an analytic sample size of 4406. (The corresponding sample size for the secondary outcome was 4404).</p><p id="P13">Descriptive statistics were used to compare baseline characteristics of the DSE and the ILI groups according to 1-year weight loss and fitness responses from baseline to one-year of follow-up. Weight loss and fitness responses during the first year were examined as both continuous (expressed per standard deviation of weight loss and fitness increase) and categorical variables. We used the following cut points to assign categories of weight change: weight gain or weight stable (&#x0003c;2% weight loss or weight gain), small (&#x0003e; 2 to &#x0003c; 5% weight loss), moderate (&#x0003e; 5 to &#x0003c; 10 % loss), or large (&#x0003e; 10%) weight loss. We defined the large weight loss as &#x0003e; 10% because it corresponded with the intervention weight loss goal. Fitness change was categorized in terms of metabolic equivalents (METs) as fitness loss/stable (fitness gain &#x0003c; 0.5 METS), small (&#x0003e;0.5 to &#x0003c;1.0), moderate (&#x0003e;1.0 to &#x0003c;2.0), or large (&#x02265;2.0 MET) change.</p><p id="P14">We conducted analyses from two distinct perspectives. First, we compared event rates across the categories of weight change and fitness change for the overall Look AHEAD study sample, with DSE and ILI groups combined, setting the stable weight group as the referent group. Second, we compared CVD rates in ILI participants according to their weight change and fitness response to lifestyle intervention, treating the DSE group as the referent group. The second analysis was undertaken to determine whether, compared to receiving DSE, receiving ILI and having a favorable response to ILI resultedresult in a reduced CVD incidence. In pharmacological trials, this analysis is sometimes referred to as a &#x0201c;per protocol&#x0201d; or &#x0201c;on treatment&#x0201d; analysis. We also tested interactions of randomization group by weight change and randomization group by fitness change on the primary outcome. For both analyses, we first calculated crude rates, then fit Cox proportional hazards regression models, adjusting for factors that varied across weight change or fitness change groups: age, sex, diabetes duration, insulin use, history of CVD, baseline smoking status, baseline weight, LDL cholesterol (LDL), systolic blood pressure (SBP) and diastolic blood pressure (DBP). We tested for non-linearity of the association of weight change and fitness change with CVD incidence and examined interactions of weight change and fitness change with the protocol-based pre-specified variables of age, CVD history, and race/ethnicity. All analyses were performed using SAS (Cary, NC). A two-sided p-value of less than 0.05 was considered statistically significant.</p></sec></sec><sec sec-type="results" id="S12"><title>RESULTS</title><p id="P15">Between the baseline and first-year visits, 40% of the overall sample had stable weight or gained weight, whereas roughly 20% fell into each of the 3 weight loss categories: lost 2&#x02013;5%, 5&#x02013;10% or &#x0003e;10%. ILI participants represented only 18% of the weight stable/gain group, but 92% of those who lost &#x0003e;10% of weight. Participants with larger weight losses were older, more likely to be white, less likely to be taking insulin, and had lower LDL cholesterol and diastolic blood pressure than persons with stable weight or a weight gain (<xref ref-type="table" rid="T1">Table 1</xref>).</p><p id="P16">Fifty-two percent of the overall sample had a decline or no change in fitness between baseline and 1 year, whereas the remaining 48% fell roughly evenly into the 3 fitness change categories: gain 0.5 to 1.0 MET, 1.0 to 2.0 MET, &#x0003e; 2.0 MET (<xref ref-type="table" rid="T1">Table 1</xref>). ILI participants represented only 37% of those with no fitness improvement, increasing to 79% of persons with fitness gain &#x0003e; 2.0 MET. Similarly, persons with large fitness improvements were more likely to be men, white, of younger age, less likely to have CVD, have lower BMI, and have lower systolic blood pressure than those with no fitness improvement.</p><sec id="S13"><title>Analyses with ILI and DSE groups combined</title><p id="P17">In multivariate analyses (adjusting for adjusting for age, sex, baseline weight or baseline fitness, insulin use, diabetes duration, CVD history, LDL, SBP, DBP, smoking), combining participants in the DSE and ILI groups, those who lost at least 10% of body weight in the first year had a 21% lower risk of the primary outcome (HR=0.79, 95% CI, 0.64 to 0.98) and a 24% reduced risk of the secondary outcome (HR=0.76, 95% CI, 0.63 to 0.91) compared to those with stable weight/weight gain (<xref ref-type="table" rid="T2">Table 2</xref>). There was a significant association of weight change with CVD incidence across the full spectrum of weight loss groups for the secondary outcome (p for trend=0.006) but not the primary outcome (p for trend=0.17).</p><p id="P18">Greater increases in fitness were associated with a reduced incidence of CVD for both the primary outcome (p for trend=0.03) and the secondary outcome (p for trend=0.003). Specifically, a &#x0003e; 2 MET increase in fitness was associated with a reduced risk of the secondary outcome (HR=0.77, 95% CI, 0.61 &#x02013; 0.96) but not the primary outcome (HR=0.78, 0.60 &#x02013; 1.03). Analyses of the association of weight loss and fitness change with Look AHEAD&#x02019;s other pre-specified secondary outcomes (<xref ref-type="table" rid="T6">Appendix Table 3</xref>) were similar to the outcomes described above.</p><p id="P19">In analyses within DSE and ILI groups (<xref ref-type="table" rid="T4">Appendix Tables 1</xref>&#x02013;<xref ref-type="table" rid="T5">2</xref>), HRs for the primary and secondary CVD outcomes associated with weight loss and fitness change were similar and there was no significant interactions of weight change or fitness change by intervention group with regard to their effect on the primary or secondary outcome. However, the associations of weight change and fitness change with CVD incidence were only significant for the ILI group, as there were more people in the large weight loss and fitness groups in ILI than in DSE, for which confidence intervals were broad.</p></sec><sec id="S14"><title>Analyses Comparing ILI Weight and Fitness Change Groups to DSE as Referent</title><p id="P20">In multivariate analyses of the primary outcome (adjusting for age, sex, baseline weight or baseline fitness, insulin use, diabetes duration, CVD history, LDL, SBP, DBP, smoking), and treating the DSE group as the referent group, ILI participants with &#x0003e; 10% weight loss had a 20% reduced risk of the primary outcome (HR=0.80, 95% CI, 0.65 to 0.99) and a 21% reduced risk of the secondary outcome (HR=0.79, 95% CI, 0.66&#x02013;0.95) (<xref ref-type="table" rid="T3">Table 3</xref>). Persons with a weight gain/stable weight had a 28% increased risk (HR=1.28, 95% CI, 1.01&#x02013;1.64) of the secondary outcome (<xref ref-type="table" rid="T3">Table 3</xref>). Each SD of weight loss (about 7%) was associated with a 15% lower risk (HR =0.85, 95% CI, 0.76 &#x02013; 0.95) of the primary outcome and 18% lower risk (HR=0.82, 95% CI, 0.74 &#x02013; 0.90) of the secondary outcome compared to the DSE group (<xref ref-type="table" rid="T2">Table 2</xref>). Analyses of the association of weight loss and fitness change with Look AHEAD&#x02019;s other pre-specified secondary outcomes were similar to the outcomes described above (<xref ref-type="table" rid="T7">Appendix Table 4</xref>).</p><p id="P21">Compared to persons in the DSE groups, there were no significant differences in risk of either the primary or secondary outcome according to the level of ILI-related fitness change. We also found no evidence of a non-linear relationship between weight change or fitness change and CVD incidence and no significant interactions between weight loss or fitness change and race/ethnicity, sex, or history of CVD at baseline.</p></sec></sec><sec sec-type="discussion" id="S15"><title>DISCUSSION</title><p id="P22">In these secondary analyses of the overall cohort (ILI and DSE participants combined), achievement of a 10% weight loss or a 2 MET fitness increase in the first year was associated with an approximate 20% reduced CVD risk while there was no association of small or moderate weight loss with CVD risk. Analyses comparing ILI participants who met the 10% weight loss goal to the full group of DSE participants yielded a similar reduction in CVD incidence. As such, this is one of the first studies to-date, of either observational or randomized design, to observe an association of lifestyle-based weight loss with reduced CVD incidence. Significant reductions in CVD mortality reduction were observed in the Da Qing Diabetes Prevention Follow-up Study and reducing in CVD incidence from Mediterranean diet in the PREDIMED Study, although those trials were conducted in largely non-diabetic populations and achieved the effect with modest or no weight loss (<xref rid="R22" ref-type="bibr">22</xref>, <xref rid="R23" ref-type="bibr">23</xref>).</p><p id="P23">There are subtle but important differences in interpretation between the two analyses presented, that may complement the original null ITT findings. The analyses of the combined cohort suggest that greater weight loss or fitness gain, achieved through possibly diverse pathways including the study intervention, self-driven behavior change, or other patient characteristics, is associated with reduced CVD risk. The comparison between ILI weight loss response groups and DSE indicates that individuals who respond well to intervention by meeting the first-year intervention goals, have a 20% reduction in the CVD incidence compared to persons not receiving the intervention. These findings should not be confused with the primary intent-to-treat analysis, which showed that weight loss intervention had no significant effect on either the primary outcome or secondary outcomes. Taken together, these analyses suggest that the ILI in Look AHEAD did not achieve a large enough weight loss or fitness change among enough people to affect CVD incidence. However, these findings highlight the variation of reponses to lifestyle intervention, and resulting outcomes, that may result from lifestyle interntion.</p><p id="P24">The amount of weight loss that was associated with benefit (&#x02265;10% weight loss) in the overall cohort analysis was achieved by almost 40% of the lifestyle intervention participants. Previous Look AHEAD analyses have shown that attainment of the weight loss goal was associated with more consistent attendance at intervention sessions, and with higher levels of reported physical activity, lower caloric intake, and more consistent self-monitoring (<xref rid="R16" ref-type="bibr">16</xref>). That study also found that among persons who met the one-year weight loss goal of 10%, 42 percent maintained at least 10% weight loss and 70% maintained at least 5% weight loss at four years. Previous studies have also shown that the amount of weight change is generally associated with the dosage of behavioral support, with optimal efficacy observed when supported by a multidisciplinary team of specialists in nutrition, exercise, and behavior change (<xref rid="R15" ref-type="bibr">15</xref>).</p><p id="P25">These findings should be interpreted cautiously because of the potential for unmeasured confounding and selection bias that remain in secondary analyses. For example, ILI participants with large weight loss may have better underlying health or health behaviors to facilitate weight loss, or could have more actively sought or received preventive health care. The observation that intervention participants who had stable weight or a small weight gain (14% of the sample) had a higher rate of the secondary outcome than DSE participants may be further evidence of this. These types of biases have been reflected in previous studies showing that persons who adhere to a placebo have better health outcomes than those who do not (<xref rid="R24" ref-type="bibr">24</xref>). Given these concerns, our findings should not be considered a modification of the primary conclusions of Look AHEAD, and causality cannot be inferred from these findings. Instead they should stimulate closer examination of the characteristics and factors underlying persons who respond particularly well to lifestyle intervention and whether there are practical ways of identifying them for referral for lifestyle interventions (<xref rid="R18" ref-type="bibr">18</xref>, <xref rid="R25" ref-type="bibr">25</xref>).</p><p id="P26">Our study has some additional limitations. These analyses used one-year weight change because using a longer period of intervention response results in shorter follow-up after the period of intervention response assessment, considerably compromising statistical power. However, while one-year weight loss and fitness change are only proxies for sustained intervention response, shorter-term responses to intervention are highly correlated with longer-term responses term responses (<xref rid="R26" ref-type="bibr">26</xref>). These analyses were not intended to uncover the primary factors or covariates explaining the associations of weight change and fitness change with the study outcomes. In addition, our analyses did not adjust for randomization arm because of the high degree of collinearity between randomization arm and weight loss group, as 92% of the large weight loss group were ILI participants, and conversely 82% of the weight gain/weight stable group were DSE participants. However, our analyses adjusted for all variables that were observed to differ between the ILI and DSE groups, including CVD risk factors (blood pressure, lipid levels, smoking, CVD history) that have been consistently associated with CVD incidence. Of note, CVD history in this analysis was the most influential covariate, as its inclusion in the model strengthened the magnitude of association slightly by itself.</p><p id="P27">Although the current cohort study findings associate weight loss with reduced CVD incidence, they should not be interpreted to support 10% weight loss as a necessary target for lifestyle interventions in all settings. Previous RCTs have demonstrated large benefits on diabetes, hypertension, and disability with more modest weight loss (e.g., 5 to 7%) without major risks (<xref rid="R6" ref-type="bibr">6</xref>, <xref rid="R7" ref-type="bibr">7</xref>, <xref rid="R11" ref-type="bibr">11</xref>, <xref rid="R27" ref-type="bibr">27</xref>, <xref rid="R28" ref-type="bibr">28</xref>). Weight losses of 10% or greater may carry additional risk of adverse outcomes, including gallstone disease or bone loss in older adults (<xref rid="R29" ref-type="bibr">29</xref>) (<xref rid="R30" ref-type="bibr">30</xref>, <xref rid="R31" ref-type="bibr">31</xref>). It is also noteworthy that the study sample had a very high baseline BMI (mean=36); although our analyses adjusted for baseline level of obesity, findings could conceivably differ in a leaner sample of adults with diabetes. Thus, recommendations related to the magnitude of weight loss should consider diverse factors, including the characteristics and needs of the participants, mode of weight loss, and the priority outcomes for prevention.</p><p id="P28">In summary, these secondary analyses, combined with the primary Look AHEAD study findings, lead to the following conclusions about the impact of intentional weight loss. First, as reported previously, the primary analyses using intention to treat indicate lifestyle intervention does not result in reduced CVD relative to DSE. However, analyses suggest that greater magnitude of weight loss was associated with lower CVD incidence in the total cohort and within ILI. These findings, combined with evidence for reduced incidence of diabetes, hypertension, disability, and other benefits indicate a need to continue to refine approaches to identify participants most likely to benefit from lifestyle interventions, and to develop strategies to improve the magnitude of sustained weight loss to lifestyle interventions (<xref rid="R6" ref-type="bibr">6</xref>, <xref rid="R11" ref-type="bibr">11</xref>, <xref rid="R27" ref-type="bibr">27</xref>).</p></sec><sec sec-type="supplementary-material" id="SM"><title>Supplementary Material</title><supplementary-material content-type="local-data" id="SD1"><label>1</label><media xlink:href="NIHMS814901-supplement-1.pdf" orientation="portrait" xlink:type="simple" id="d37e336" position="anchor"/></supplementary-material></sec></body><back><fn-group><fn id="FN2"><p id="P29" content-type="publisher-disclaimer">This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final citable form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.</p></fn><fn id="FN3"><p id="P30">Trial Registration <ext-link ext-link-type="uri" xlink:href="http://clinicaltrials.gov">clinical trials.gov</ext-link> identifier: NCT00017953</p></fn></fn-group><ack id="S16"><p id="P86"><underline><bold>Funding and Support</bold></underline></p><p id="P87">Funded by the National Institutes of Health through cooperative agreements with the National Institute of Diabetes and Digestive and Kidney Diseases: DK57136, DK57149, DK56990, DK57177, DK57171, DK57151, DK57182, DK57131, DK57002, DK57078, DK57154, DK57178, DK57219, DK57008, DK57135, and DK56992. Additional funding was provided by the National Heart, Lung, and Blood Institute; National Institute of Nursing Research; National Center on Minority Health and Health Disparities; NIH Office of Research on Women&#x02019;s Health; and the Centers for Disease Control and Prevention. This research was supported in part by the Intramural Research Program of the National Institute of Diabetes and Digestive and Kidney Diseases. The Indian Health Service (I.H.S.) provided personnel, medical oversight, and use of facilities. The opinions expressed in this paper are those of the authors and do not necessarily reflect the views of the I.H.S. or other funding sources.</p><p id="P88">Additional support was received from The Johns Hopkins Medical Institutions Bayview General Clinical Research Center (M01RR02719); the Massachusetts General Hospital Mallinckrodt General Clinical Research Center and the Massachusetts Institute of Technology General Clinical Research Center (M01RR01066); the University of Colorado Health Sciences Center General Clinical Research Center (M01RR00051) and Clinical Nutrition Research Unit (P30 DK48520); the University of Tennessee at Memphis General Clinical Research Center (M01RR0021140); the University of Pittsburgh General Clinical Research Center (GCRC) (M01RR000056), the Clinical Translational Research Center (CTRC) funded by the Clinical &#x00026; Translational Science Award (UL1 RR 024153) and NIH grant (DK 046204); the VA Puget Sound Health Care System Medical Research Service, Department of Veterans Affairs; and the Frederic C. Bartter General Clinical Research Center (M01RR01346).</p><p id="P89">The following organizations have committed to make major contributions to Look AHEAD: FedEx Corporation; Health Management Resources; LifeScan, Inc., a Johnson &#x00026; Johnson Company; OPTIFAST<sup>&#x000ae;</sup> of Nestle HealthCare Nutrition, Inc.; Hoffmann-La Roche Inc.; Abbott Nutrition; and Slim-Fast Brand of Unilever North America.</p><p id="P90">Some of the information contained herein was derived from data provided by the Bureau of Vital Statistics, New York City Department of Health and Mental Hygiene.</p></ack><app-group><app id="APP1"><title>Appendix</title><table-wrap id="T4" position="anchor" orientation="portrait"><label>Appendix Table 1</label><caption><p id="P31">Primary and Secondary Outcomes Associated with Percent Weight Change, Stratified by Randomization Group</p></caption><table frame="hsides" rules="cols"><tbody><tr><td align="left" rowspan="1" colspan="1"/><td align="center" colspan="4" rowspan="1"><bold>Weight Change Groups (percent weight loss in first year)</bold></td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="center" colspan="6" valign="bottom" rowspan="1"><hr/></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"><bold>ILI Group</bold></td><td align="center" rowspan="1" colspan="1"><bold>Gain /Stable</bold><break/><bold>(&#x0003c;2% loss)</bold></td><td align="center" rowspan="1" colspan="1"><bold>Small Loss</bold><break/><bold>(2 to 5%)</bold></td><td align="center" rowspan="1" colspan="1"><bold>Medium Loss</bold><break/><bold>(5 to 10%)</bold></td><td align="center" rowspan="1" colspan="1"><bold>Large Loss</bold><break/><bold>(&#x02265;10%)</bold></td><td align="left" rowspan="1" colspan="1"><bold>Test for</bold><break/><bold>Trend</bold></td></tr><tr><td align="left" colspan="6" valign="bottom" rowspan="1"><hr/></td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Primary Outcome</bold></td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Events / person years</td><td align="center" rowspan="1" colspan="1">58 / 3096</td><td align="center" rowspan="1" colspan="1">69 / 3766</td><td align="center" rowspan="1" colspan="1">114 / 6446</td><td align="center" rowspan="1" colspan="1">120 / 8257</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Crude rate/100 person years</td><td align="center" rowspan="1" colspan="1">1.87</td><td align="center" rowspan="1" colspan="1">1.83</td><td align="center" rowspan="1" colspan="1">1.77</td><td align="center" rowspan="1" colspan="1">1.45</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Unadjusted HR (95% C.I.)</td><td align="center" rowspan="1" colspan="1">REF</td><td align="center" rowspan="1" colspan="1">0.94 (0.66 &#x02013; 1.33)</td><td align="center" rowspan="1" colspan="1">0.91 (0.66 &#x02013; 1.25)</td><td align="center" rowspan="1" colspan="1">0.72 (0.52 &#x02013; 0.99)*</td><td align="left" rowspan="1" colspan="1">0.03</td></tr><tr><td align="left" rowspan="1" colspan="1">Adjusted HR <xref ref-type="table-fn" rid="TFN5">&#x001c2;</xref> (95% C.I.)</td><td align="center" rowspan="1" colspan="1">REF</td><td align="center" rowspan="1" colspan="1">0.78(0.54 &#x02013; 1.13)</td><td align="center" rowspan="1" colspan="1">0.89 (0.63 &#x02013; 1.25)</td><td align="center" rowspan="1" colspan="1">0.61 (0.44 &#x02013; 0.86)*</td><td align="left" rowspan="1" colspan="1">0.007</td></tr><tr><td align="center" colspan="6" valign="bottom" rowspan="1"><hr/></td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Secondary Outcome</bold></td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Events / person years</td><td align="center" rowspan="1" colspan="1">82 / 3018</td><td align="center" rowspan="1" colspan="1">108 / 3643</td><td align="center" rowspan="1" colspan="1">151 / 6335</td><td align="center" rowspan="1" colspan="1">173 / 8127</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Crude rate/100 person years</td><td align="center" rowspan="1" colspan="1">2.72</td><td align="center" rowspan="1" colspan="1">2.96</td><td align="center" rowspan="1" colspan="1">2.38</td><td align="center" rowspan="1" colspan="1">2.13</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Unadjusted HR (95% C.I.)</td><td align="center" rowspan="1" colspan="1">REF</td><td align="center" rowspan="1" colspan="1">1.04 (0.78 &#x02013; 1.39)</td><td align="center" rowspan="1" colspan="1">0.84 (0.64 &#x02013; 1.10)</td><td align="center" rowspan="1" colspan="1">0.73 (0.56 &#x02013; 0.96)*</td><td align="left" rowspan="1" colspan="1">0.003</td></tr><tr><td align="left" rowspan="1" colspan="1">Adjusted HR <xref ref-type="table-fn" rid="TFN5">&#x001c2;</xref> (95% C.I.)</td><td align="center" rowspan="1" colspan="1">REF</td><td align="center" rowspan="1" colspan="1">0.90 (0.67 &#x02013; 1.22)</td><td align="center" rowspan="1" colspan="1">0.79 (0.59 &#x02013; 1.05)</td><td align="center" rowspan="1" colspan="1">0.61 (0.45 &#x02013; 0.80)*</td><td align="left" rowspan="1" colspan="1">&#x0003c;0.0001</td></tr><tr><td align="center" colspan="6" valign="bottom" rowspan="1"><hr/></td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="center" colspan="4" rowspan="1"><bold>Weight Change Groups (percent weight loss in first year)</bold></td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="center" colspan="6" valign="bottom" rowspan="1"><hr/></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"><bold>DSE Group</bold></td><td align="center" rowspan="1" colspan="1"><bold>Gain /Stable</bold><break/><bold>(&#x0003c;2% loss)</bold></td><td align="center" rowspan="1" colspan="1"><bold>Small Loss</bold><break/><bold>(2 to 5%)</bold></td><td align="center" rowspan="1" colspan="1"><bold>Medium Loss</bold><break/><bold>(5 to 10%)</bold></td><td align="center" rowspan="1" colspan="1"><bold>Large Loss</bold><break/><bold>(&#x02265;10%)</bold></td><td align="left" rowspan="1" colspan="1"><bold>Test for</bold><break/><bold>Trend</bold></td></tr><tr><td align="center" colspan="6" valign="bottom" rowspan="1"><hr/></td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Primary Outcome</bold></td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Events / person years</td><td align="center" rowspan="1" colspan="1">231 / 13978</td><td align="center" rowspan="1" colspan="1">72 / 4104</td><td align="center" rowspan="1" colspan="1">40 / 2124</td><td align="center" rowspan="1" colspan="1">8 / 685</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Crude rate/100 person years</td><td align="center" rowspan="1" colspan="1">1.65</td><td align="center" rowspan="1" colspan="1">1.75</td><td align="center" rowspan="1" colspan="1">1.88</td><td align="center" rowspan="1" colspan="1">1.17</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Unadjusted HR (95% C.I.)</td><td align="center" rowspan="1" colspan="1">REF</td><td align="center" rowspan="1" colspan="1">1.10 (0.84 &#x02013; 1.43)</td><td align="center" rowspan="1" colspan="1">1.16 (0.82 &#x02013; 1.62)</td><td align="center" rowspan="1" colspan="1">0.72 (0.35 &#x02013; 1.45)</td><td align="left" rowspan="1" colspan="1">0.82</td></tr><tr><td align="left" rowspan="1" colspan="1">Adjusted HR <xref ref-type="table-fn" rid="TFN5">&#x001c2;</xref> (95% C.I.)</td><td align="center" rowspan="1" colspan="1">REF</td><td align="center" rowspan="1" colspan="1">1.17 (0.89 &#x02013; 1.54)</td><td align="center" rowspan="1" colspan="1">1.26 (0.88 &#x02013; 1.79)</td><td align="center" rowspan="1" colspan="1">0.71 (0.33 &#x02013; 1.51)</td><td align="left" rowspan="1" colspan="1">0.51</td></tr><tr><td align="center" colspan="6" valign="bottom" rowspan="1"><hr/></td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Secondary Outcome</bold></td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Events / person years</td><td align="center" rowspan="1" colspan="1">340 / 13681</td><td align="center" rowspan="1" colspan="1">98 / 4014</td><td align="center" rowspan="1" colspan="1">52 / 2076</td><td align="center" rowspan="1" colspan="1">13 / 665</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Crude rate/100 person years</td><td align="center" rowspan="1" colspan="1">2.49</td><td align="center" rowspan="1" colspan="1">2.44</td><td align="center" rowspan="1" colspan="1">2.50</td><td align="center" rowspan="1" colspan="1">1.95</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Unadjusted HR (95% C.I.)</td><td align="center" rowspan="1" colspan="1">REF</td><td align="center" rowspan="1" colspan="1">1.02 (0.81 &#x02013; 1.27)</td><td align="center" rowspan="1" colspan="1">1.03 (0.77 &#x02013; 1.38)</td><td align="center" rowspan="1" colspan="1">0.80 (0.46 &#x02013; 1.40)</td><td align="left" rowspan="1" colspan="1">0.76</td></tr><tr><td align="left" rowspan="1" colspan="1">Adjusted HR <xref ref-type="table-fn" rid="TFN5">&#x001c2;</xref> (95% C.I.)</td><td align="center" rowspan="1" colspan="1">REF</td><td align="center" rowspan="1" colspan="1">1.01 (0.79 &#x02013; 1.27)</td><td align="center" rowspan="1" colspan="1">0.99 (0.73 &#x02013; 1.35)</td><td align="center" rowspan="1" colspan="1">0.77 (0.42 &#x02013; 1.42)</td><td align="left" rowspan="1" colspan="1">0.67</td></tr></tbody></table><table-wrap-foot><fn id="TFN5"><label>&#x001c2;</label><p id="P32">adjusted for sex, age, baseline weight(percent weight loss models), baseline fitness (fitness change models),CVD history, insulin use, diabetes duration, smoking status, LDL, SBP, DBP. Primary Outcome: (non-fatal MI, stroke, hospitalized angina, CVD death); Secondary Outcome: (non-fatal MI, stroke, hospitalized angina, CABG/PTCA, hospitalized CHF, carotid endarterectomy, PVD, total mortality)</p></fn></table-wrap-foot></table-wrap><table-wrap id="T5" position="anchor" orientation="portrait"><label>Appendix Table 2</label><caption><p id="P33">Primary and Secondary Outcomes Associated with Fitness Change, Stratified by Randomization Group.</p></caption><table frame="hsides" rules="cols"><tbody><tr><td align="left" rowspan="1" colspan="1"/><td align="center" colspan="4" rowspan="1"><bold>Fitness Change Groups (METs change in first-year)</bold></td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="center" colspan="6" valign="bottom" rowspan="1"><hr/></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"><bold>ILI Group</bold></td><td align="center" rowspan="1" colspan="1"><bold>Loss/Stable</bold><break/><bold>(&#x0003c;0.5)</bold></td><td align="center" rowspan="1" colspan="1"><bold>Small Gain</bold><break/><bold>(0.5 to 1.0)</bold></td><td align="center" rowspan="1" colspan="1"><bold>Medium Gain</bold><break/><bold>(1.0 to 2.0)</bold></td><td align="center" rowspan="1" colspan="1"><bold>Large Gain</bold><break/><bold>(&#x02265;2.0)</bold></td><td align="left" valign="top" rowspan="1" colspan="1"><bold>Test for Trend</bold></td></tr><tr><td align="center" colspan="6" valign="bottom" rowspan="1"><hr/></td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Primary Outcome</bold></td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Events / person years</td><td align="center" rowspan="1" colspan="1">139 / 7731</td><td align="center" rowspan="1" colspan="1">53 / 3082</td><td align="center" rowspan="1" colspan="1">64 / 4744</td><td align="center" rowspan="1" colspan="1">59 / 4190</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Crude rate/100 person years</td><td align="center" rowspan="1" colspan="1">1.80</td><td align="center" rowspan="1" colspan="1">1.72</td><td align="center" rowspan="1" colspan="1">1.35</td><td align="center" rowspan="1" colspan="1">1.41</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Unadjusted HR (95% C.I.)</td><td align="center" rowspan="1" colspan="1">REF</td><td align="center" rowspan="1" colspan="1">0.93 (0.68 &#x02013; 1.28)</td><td align="center" rowspan="1" colspan="1">0.74 (0.55 &#x02013; 0.99)*</td><td align="center" rowspan="1" colspan="1">0.78 (0.57 &#x02013; 1.07)</td><td align="left" rowspan="1" colspan="1">0.04</td></tr><tr><td align="left" rowspan="1" colspan="1">Adjusted HR<xref ref-type="table-fn" rid="TFN6">&#x001c2;</xref>(95% C.I.)</td><td align="center" rowspan="1" colspan="1">REF</td><td align="center" rowspan="1" colspan="1">0.91 (0.65 &#x02013; 1.27)</td><td align="center" rowspan="1" colspan="1">0.74 (0.54 &#x02013; 1.01)</td><td align="center" rowspan="1" colspan="1">0.80 (0.58 &#x02013; 1.12)</td><td align="left" rowspan="1" colspan="1">0.08</td></tr><tr><td align="center" colspan="6" valign="bottom" rowspan="1"><hr/></td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Secondary Outcome</bold></td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Events / person years</td><td align="center" rowspan="1" colspan="1">197 / 7564</td><td align="center" rowspan="1" colspan="1">78 / 3041</td><td align="center" rowspan="1" colspan="1">92 / 4663</td><td align="center" rowspan="1" colspan="1">86 / 4111</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Crude rate/100 person years</td><td align="center" rowspan="1" colspan="1">2.60</td><td align="center" rowspan="1" colspan="1">2.57</td><td align="center" rowspan="1" colspan="1">1.97</td><td align="center" rowspan="1" colspan="1">2.09</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Unadjusted HR (95% C.I.)</td><td align="center" rowspan="1" colspan="1">REF</td><td align="center" rowspan="1" colspan="1">0.95 (0.73 &#x02013; 1.24)</td><td align="center" rowspan="1" colspan="1">0.74 (0.58 &#x02013; 0.95)*</td><td align="center" rowspan="1" colspan="1">0.79 (0.61 &#x02013; 1.03)</td><td align="left" rowspan="1" colspan="1">0.02</td></tr><tr><td align="left" rowspan="1" colspan="1">Adjusted HR<xref ref-type="table-fn" rid="TFN6">&#x001c2;</xref>(95% C.I.)</td><td align="center" rowspan="1" colspan="1">REF</td><td align="center" rowspan="1" colspan="1">0.95 (0.72 &#x02013; 1.25)</td><td align="center" rowspan="1" colspan="1">0.70 (0.54 &#x02013; 0.91)*</td><td align="center" rowspan="1" colspan="1">0.80 (0.61 &#x02013; 1.06)</td><td align="left" rowspan="1" colspan="1">0.02</td></tr><tr><td align="center" colspan="6" valign="bottom" rowspan="1"><hr/></td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="center" colspan="4" rowspan="1"><bold>Fitness Change Groups (METs change in first-year)</bold></td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="center" colspan="6" valign="bottom" rowspan="1"><hr/></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"><bold>DSE Group</bold></td><td align="center" rowspan="1" colspan="1"><bold>Loss/Stable</bold><break/><bold>(&#x0003c;0.5)</bold></td><td align="center" rowspan="1" colspan="1"><bold>Small Gain</bold><break/><bold>(0.5 to 1.0)</bold></td><td align="center" rowspan="1" colspan="1"><bold>Medium Gain</bold><break/><bold>(1.0 to 2.0)</bold></td><td align="center" rowspan="1" colspan="1"><bold>Large Gain</bold><break/><bold>(&#x02265;2.0)</bold></td><td align="left" valign="top" rowspan="1" colspan="1"><bold>Test for Trend</bold></td></tr><tr><td align="center" colspan="6" valign="bottom" rowspan="1"><hr/></td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Primary Outcome</bold></td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Events / person years</td><td align="center" rowspan="1" colspan="1">208 / 12266</td><td align="center" rowspan="1" colspan="1">42 / 3009</td><td align="center" rowspan="1" colspan="1">38 / 2439</td><td align="center" rowspan="1" colspan="1">13 / 1122</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Crude rate/100 person years</td><td align="center" rowspan="1" colspan="1">1.70</td><td align="center" rowspan="1" colspan="1">1.40</td><td align="center" rowspan="1" colspan="1">1.56</td><td align="center" rowspan="1" colspan="1">1.16</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Unadjusted HR (95% C.I.)</td><td align="center" rowspan="1" colspan="1">REF</td><td align="center" rowspan="1" colspan="1">0.80 (0.57 &#x02013; 1.12)</td><td align="center" rowspan="1" colspan="1">0.89 (0.63 &#x02013; 1.26)</td><td align="center" rowspan="1" colspan="1">0.65 (0.37 &#x02013; 1.13)</td><td align="left" rowspan="1" colspan="1">0.09</td></tr><tr><td align="left" rowspan="1" colspan="1">Adjusted HR<xref ref-type="table-fn" rid="TFN6">&#x001c2;</xref>(95% C.I.)</td><td align="center" rowspan="1" colspan="1">REF</td><td align="center" rowspan="1" colspan="1">0.77 (0.54 &#x02013; 1.10)</td><td align="center" rowspan="1" colspan="1">0.98 (0.68 &#x02013; 1.40)</td><td align="center" rowspan="1" colspan="1">0.66 (0.37 &#x02013; 1.17)</td><td align="left" rowspan="1" colspan="1">0.19</td></tr><tr><td align="center" colspan="6" valign="bottom" rowspan="1"><hr/></td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Secondary Outcome</bold></td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Events / person years</td><td align="center" rowspan="1" colspan="1">307 / 12032</td><td align="center" rowspan="1" colspan="1">53 / 2955</td><td align="center" rowspan="1" colspan="1">307 / 12032</td><td align="center" rowspan="1" colspan="1">14 / 1109</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Crude rate/100 person years</td><td align="center" rowspan="1" colspan="1">2.55</td><td align="center" rowspan="1" colspan="1">1.79</td><td align="center" rowspan="1" colspan="1">2.22</td><td align="center" rowspan="1" colspan="1">1.26</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Unadjusted HR (95% C.I.)</td><td align="center" rowspan="1" colspan="1">REF</td><td align="center" rowspan="1" colspan="1">0.68 (0.51 &#x02013; 0.91)*</td><td align="center" rowspan="1" colspan="1">0.86 (0.64 &#x02013; 1.16)</td><td align="center" rowspan="1" colspan="1">0.49 (0.28 &#x02013; 0.83)*</td><td align="left" rowspan="1" colspan="1">0.003</td></tr><tr><td align="left" rowspan="1" colspan="1">Adjusted HR<xref ref-type="table-fn" rid="TFN6">&#x001c2;</xref>(95% C.I.)</td><td align="center" rowspan="1" colspan="1">REF</td><td align="center" rowspan="1" colspan="1">0.69 (0.51 &#x02013; 0.93)*</td><td align="center" rowspan="1" colspan="1">0.90 (0.66 &#x02013; 1.23)</td><td align="center" rowspan="1" colspan="1">0.54 (0.31 &#x02013; 0.94)*</td><td align="left" rowspan="1" colspan="1">0.02</td></tr></tbody></table><table-wrap-foot><fn id="TFN6"><label>&#x001c2;</label><p id="P34">adjusted for sex, age, baseline weight(percent weight loss models), baseline fitness (fitness change models), CVD history, insulin use, diabetes duration, baseline fitness smoking status, LDL, SBP, DBP. Primary Outcome: (non-fatal MI, stroke, hospitalized angina, CVD death); Secondary Outcome: (non-fatal MI, stroke, hospitalized angina, CABG/PTCA, hospitalized CHF, carotid endarterectomy, PVD, total mortality</p></fn></table-wrap-foot></table-wrap><table-wrap id="T6" position="anchor" orientation="portrait"><label>Appendix Table 3</label><caption><p id="P35">Association of weight change and fitness change with additional Look AHEAD Pre-specified Secondary Outcomes.</p></caption><table frame="hsides" rules="cols"><tbody><tr><td align="left" rowspan="1" colspan="1"/><td align="center" colspan="4" rowspan="1"><bold>Weight Change Groups (percent weight loss in first year)</bold></td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="center" colspan="6" valign="bottom" rowspan="1"><hr/></td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"><bold>Gain /Stable</bold><break/><bold>(&#x0003c;2% loss)</bold></td><td align="center" rowspan="1" colspan="1"><bold>Small Loss</bold><break/><bold>(2 to 5%)</bold></td><td align="center" rowspan="1" colspan="1"><bold>Medium Loss</bold><break/><bold>(5 to 10%)</bold></td><td align="center" rowspan="1" colspan="1"><bold>Large Loss</bold><break/><bold>(&#x02265;10%)</bold></td><td align="center" valign="top" rowspan="1" colspan="1"><bold>Test for Trend</bold></td></tr><tr><td align="center" colspan="6" valign="bottom" rowspan="1"><hr/></td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Secondary Outcome 1</bold></td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Events / person years</td><td align="center" rowspan="1" colspan="1">198 / 17563</td><td align="center" rowspan="1" colspan="1">87 / 8139</td><td align="center" rowspan="1" colspan="1">113 / 8785</td><td align="center" rowspan="1" colspan="1">76 / 9171</td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Crude rate/100 person years</td><td align="center" rowspan="1" colspan="1">1.13</td><td align="center" rowspan="1" colspan="1">1.07</td><td align="center" rowspan="1" colspan="1">1.29</td><td align="center" rowspan="1" colspan="1">0.83</td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Unadjusted HR (95% C.I.)</td><td align="center" rowspan="1" colspan="1">1.0</td><td align="center" rowspan="1" colspan="1">0.96 (0.75 &#x02013; 1.24)</td><td align="center" rowspan="1" colspan="1">1.16 (0.92 &#x02013; 1.46)</td><td align="center" rowspan="1" colspan="1">0.71 (0.55 &#x02013; 0.93)<xref ref-type="table-fn" rid="TFN8">*</xref></td><td align="center" rowspan="1" colspan="1">0.12</td></tr><tr><td align="left" rowspan="1" colspan="1">Adjusted HR<xref ref-type="table-fn" rid="TFN7">&#x001c2;</xref>(95% C.I.)</td><td align="center" rowspan="1" colspan="1">1.0</td><td align="center" rowspan="1" colspan="1">0.94 (0.73 &#x02013; 1.22)</td><td align="center" rowspan="1" colspan="1">1.24 (0.97 &#x02013; 1.57)</td><td align="center" rowspan="1" colspan="1">0.69 (0.53 &#x02013; 0.91)<xref ref-type="table-fn" rid="TFN8">*</xref></td><td align="center" rowspan="1" colspan="1">0.12</td></tr><tr><td align="center" colspan="6" valign="bottom" rowspan="1"><hr/></td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Secondary Outcome 2</bold></td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Events / person years</td><td align="center" rowspan="1" colspan="1">369 / 17076</td><td align="center" rowspan="1" colspan="1">175 / 7870</td><td align="center" rowspan="1" colspan="1">179 / 8570</td><td align="center" rowspan="1" colspan="1">167 / 8941</td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Crude rate/100 person years</td><td align="center" rowspan="1" colspan="1">2.16</td><td align="center" rowspan="1" colspan="1">2.22</td><td align="center" rowspan="1" colspan="1">2.09</td><td align="center" rowspan="1" colspan="1">1.87</td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Unadjusted HR (95% C.I.)</td><td align="center" rowspan="1" colspan="1">1.0</td><td align="center" rowspan="1" colspan="1">1.04 (0.87 &#x02013; 1.25)</td><td align="center" rowspan="1" colspan="1">0.98 (0.82 &#x02013; 1.17)</td><td align="center" rowspan="1" colspan="1">0.85 (0.71 &#x02013; 1.02)</td><td align="center" rowspan="1" colspan="1">0.11</td></tr><tr><td align="left" rowspan="1" colspan="1">Adjusted HR<xref ref-type="table-fn" rid="TFN7">&#x001c2;</xref>(95% C.I.)</td><td align="center" rowspan="1" colspan="1">1.0</td><td align="center" rowspan="1" colspan="1">1.03 (0.86 &#x02013; 1.24)</td><td align="center" rowspan="1" colspan="1">1.03 (0.86 &#x02013; 1.24)</td><td align="center" rowspan="1" colspan="1">0.80 (0.66 &#x02013; 0.97)<xref ref-type="table-fn" rid="TFN8">*</xref></td><td align="center" rowspan="1" colspan="1">0.06</td></tr><tr><td align="center" colspan="6" valign="bottom" rowspan="1"><hr/></td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="center" colspan="4" rowspan="1"><bold>Fitness Change Groups (METs change in first-year)</bold></td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="center" colspan="6" valign="bottom" rowspan="1"><hr/></td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"><bold>Loss/Stable</bold><break/><bold>(&#x0003c;0.5)</bold></td><td align="center" rowspan="1" colspan="1"><bold>Small Gain</bold><break/><bold>(0.5 to 1.0)</bold></td><td align="center" rowspan="1" colspan="1"><bold>Medium Gain</bold><break/><bold>(1.0 to 2.0)</bold></td><td align="center" rowspan="1" colspan="1"><bold>Large Gain</bold><break/><bold>(&#x02265;2.0)</bold></td><td align="center" valign="top" rowspan="1" colspan="1"><bold>Test for Trend</bold></td></tr><tr><td align="center" colspan="6" valign="bottom" rowspan="1"><hr/></td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Secondary Outcome 1</bold></td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Events / person years</td><td align="center" rowspan="1" colspan="1">239 / 20579</td><td align="center" rowspan="1" colspan="1">65 / 6240</td><td align="center" rowspan="1" colspan="1">69 / 7335</td><td align="center" rowspan="1" colspan="1">37 / 5461</td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Crude rate/100 person years</td><td align="center" rowspan="1" colspan="1">1.16</td><td align="center" rowspan="1" colspan="1">1.04</td><td align="center" rowspan="1" colspan="1">0.94</td><td align="center" rowspan="1" colspan="1">0.68</td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Unadjusted HR (95% C.I.)</td><td align="center" rowspan="1" colspan="1">1.0</td><td align="center" rowspan="1" colspan="1">0.88 (0.67 &#x02013; 1.15)</td><td align="center" rowspan="1" colspan="1">0.80 (0.61 &#x02013; 1.04)</td><td align="center" rowspan="1" colspan="1">0.56 (0.40 &#x02013; 0.80)<xref ref-type="table-fn" rid="TFN8">*</xref></td><td align="center" rowspan="1" colspan="1">0.0008</td></tr><tr><td align="left" rowspan="1" colspan="1">Adjusted HR<xref ref-type="table-fn" rid="TFN7">&#x001c2;</xref>(95% C.I.)</td><td align="center" rowspan="1" colspan="1">1.0</td><td align="center" rowspan="1" colspan="1">0.86 (0.64 &#x02013; 1.14)</td><td align="center" rowspan="1" colspan="1">0.85 (0.64 &#x02013; 1.12)</td><td align="center" rowspan="1" colspan="1">0.59 (0.41 &#x02013; 0.85)<xref ref-type="table-fn" rid="TFN8">*</xref></td><td align="center" rowspan="1" colspan="1">0.0051</td></tr><tr><td align="center" colspan="6" valign="bottom" rowspan="1"><hr/></td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Secondary Outcome 2</bold></td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Events / person years</td><td align="center" rowspan="1" colspan="1">778 / 19997</td><td align="center" rowspan="1" colspan="1">119 / 6091</td><td align="center" rowspan="1" colspan="1">123 / 7184</td><td align="center" rowspan="1" colspan="1">85 / 5312</td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Crude rate/100 person years</td><td align="center" rowspan="1" colspan="1">2.23</td><td align="center" rowspan="1" colspan="1">1.95</td><td align="center" rowspan="1" colspan="1">1.71</td><td align="center" rowspan="1" colspan="1">1.60</td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Unadjusted HR (95% C.I.)</td><td align="center" rowspan="1" colspan="1">1.0</td><td align="center" rowspan="1" colspan="1">0.86 (0.70 &#x02013; 1.05)</td><td align="center" rowspan="1" colspan="1">0.75 (0.62 &#x02013; 0.92)<xref ref-type="table-fn" rid="TFN8">*</xref></td><td align="center" rowspan="1" colspan="1">0.70 (0.55 &#x02013; 0.88)<xref ref-type="table-fn" rid="TFN8">*</xref></td><td align="center" rowspan="1" colspan="1">0.0002</td></tr><tr><td align="left" rowspan="1" colspan="1">Adjusted HR<xref ref-type="table-fn" rid="TFN7">&#x001c2;</xref>(95% C.I.)</td><td align="center" rowspan="1" colspan="1">1.0</td><td align="center" rowspan="1" colspan="1">0.85 (0.69 &#x02013; 1.05)</td><td align="center" rowspan="1" colspan="1">0.77 (0.62 &#x02013; 0.94)<xref ref-type="table-fn" rid="TFN8">*</xref></td><td align="center" rowspan="1" colspan="1">0.73 (0.57 &#x02013; 0.93)<xref ref-type="table-fn" rid="TFN8">*</xref></td><td align="center" rowspan="1" colspan="1">0.0013</td></tr></tbody></table><table-wrap-foot><fn id="TFN7"><label>&#x001c2;</label><p id="P36">adjusted for sex, age, baseline weight(weight change models), baseline fitness (fitness change models),CVD history, insulin use, diabetes duration, smoking status, LDL, SBP, DBP.</p></fn><fn id="TFN8"><label>*</label><p id="P37">P&#x0003c; 0.05</p></fn><fn id="TFN9"><p id="P38">Secondary Outcome 1: (MI, stroke, CVD Death); Secondary Outcome 2: (non-fatal MI, stroke, hospitalized angina, CVD death, total mortality)</p></fn></table-wrap-foot></table-wrap><table-wrap id="T7" position="anchor" orientation="portrait"><label>Appendix Table 4</label><caption><p id="P39">Association of weight change and fitness change with additional Look AHEAD Pre-specified Secondary Outcomes. Comparison of DSE Condition (Referent Group) with ILI weight loss and fitness change groups.</p></caption><table frame="hsides" rules="none"><tbody><tr><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" colspan="4" rowspan="1"><bold>ILI Weight Change Groups (percent weight loss in first year)</bold></td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" colspan="6" valign="bottom" rowspan="1"><hr/></td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"><bold>Overall</bold><break/><bold>DSE</bold></td><td align="center" rowspan="1" colspan="1"><bold>Gain /Stable</bold><break/><bold>(&#x0003c;2% loss)</bold></td><td align="center" rowspan="1" colspan="1"><bold>Small Loss</bold><break/><bold>(2 to 5%)</bold></td><td align="center" rowspan="1" colspan="1"><bold>Medium Loss</bold><break/><bold>(5 to 10%)</bold></td><td align="center" rowspan="1" colspan="1"><bold>Large Loss</bold><break/><bold>(&#x02265;10%)</bold></td><td align="center" rowspan="1" colspan="1"><bold>HR per SD weight</bold><break/><bold>change</bold></td><td align="center" valign="top" rowspan="1" colspan="1"><bold>P value</bold></td></tr><tr><td align="center" colspan="8" valign="bottom" rowspan="1"><hr/></td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Secondary Outcome 1</bold></td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Events / person years</td><td align="center" rowspan="1" colspan="1">239 / 21478</td><td align="center" rowspan="1" colspan="1">38 / 3203</td><td align="center" rowspan="1" colspan="1">46 / 3872</td><td align="center" rowspan="1" colspan="1">81 / 6617</td><td align="center" rowspan="1" colspan="1">70 / 8488</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Crude rate/100 person years</td><td align="center" rowspan="1" colspan="1">1.11</td><td align="center" rowspan="1" colspan="1">1.19</td><td align="center" rowspan="1" colspan="1">1.19</td><td align="center" rowspan="1" colspan="1">1.22</td><td align="center" rowspan="1" colspan="1">0.82</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Unadjusted HR (95% C.I.)</td><td align="center" rowspan="1" colspan="1">1.0</td><td align="center" rowspan="1" colspan="1">1.08 (0.76 &#x02013; 1.53)</td><td align="center" rowspan="1" colspan="1">1.08 (0.79 &#x02013; 1.48)</td><td align="center" rowspan="1" colspan="1">1.18 (0.87 &#x02013; 1.44)</td><td align="center" rowspan="1" colspan="1">0.72 (0.55 &#x02013; 0.94)*</td><td align="center" rowspan="1" colspan="1">0.87 (0.76 &#x02013; 0.99)</td><td align="center" rowspan="1" colspan="1">0.03</td></tr><tr><td align="left" rowspan="1" colspan="1">Adjusted HR<xref ref-type="table-fn" rid="TFN10">&#x001c2;</xref>(95% C.I.)</td><td align="center" rowspan="1" colspan="1">1.0</td><td align="center" rowspan="1" colspan="1">1.15 (0.80 &#x02013; 1.65)</td><td align="center" rowspan="1" colspan="1">1.06 (0.77 &#x02013; 1.46)</td><td align="center" rowspan="1" colspan="1">1.22 (0.94 &#x02013; 1.59)</td><td align="center" rowspan="1" colspan="1">0.70 (0.54 &#x02013; 0.92)*</td><td align="center" rowspan="1" colspan="1">0.85 (0.74 &#x02013; 0.98)</td><td align="center" rowspan="1" colspan="1">0.03</td></tr><tr><td align="center" colspan="6" valign="bottom" rowspan="1"><hr/></td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Secondary Outcome 2</bold></td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Events / person years</td><td align="center" rowspan="1" colspan="1">449 / 20892</td><td align="center" rowspan="1" colspan="1">69 / 3088</td><td align="center" rowspan="1" colspan="1">86 / 3766</td><td align="center" rowspan="1" colspan="1">132 / 6447</td><td align="center" rowspan="1" colspan="1">154 / 8266</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Crude rate/100 person years</td><td align="center" rowspan="1" colspan="1">2.15</td><td align="center" rowspan="1" colspan="1">2.23</td><td align="center" rowspan="1" colspan="1">2.28</td><td align="center" rowspan="1" colspan="1">2.05</td><td align="center" rowspan="1" colspan="1">1.86</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Unadjusted HR (95% C.I.)</td><td align="center" rowspan="1" colspan="1">1.0</td><td align="center" rowspan="1" colspan="1">1.07 (0.83 &#x02013; 1.38)</td><td align="center" rowspan="1" colspan="1">1.07 (0.85 &#x02013; 1.35)</td><td align="center" rowspan="1" colspan="1">0.96 (0.79 &#x02013; 1.17)</td><td align="center" rowspan="1" colspan="1">0.85 (0.71 &#x02013; 1.02)</td><td align="center" rowspan="1" colspan="1">0.90 (0.81 &#x02013; 0.99)</td><td align="center" rowspan="1" colspan="1">0.02</td></tr><tr><td align="left" rowspan="1" colspan="1">Adjusted HR<xref ref-type="table-fn" rid="TFN10">&#x001c2;</xref>(95% C.I.)</td><td align="center" rowspan="1" colspan="1">1.0</td><td align="center" rowspan="1" colspan="1">1.22 (0.93 &#x02013; 1.58)</td><td align="center" rowspan="1" colspan="1">1.04 (0.82 &#x02013; 1.32)</td><td align="center" rowspan="1" colspan="1">1.02 (0.84 &#x02013; 1.25)</td><td align="center" rowspan="1" colspan="1">0.80 (0.66 &#x02013; 0.97)*</td><td align="center" rowspan="1" colspan="1">0.86 (0.78 &#x02013; 0.95)</td><td align="center" rowspan="1" colspan="1">0.003</td></tr><tr><td align="center" colspan="8" valign="bottom" rowspan="1"><hr/></td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="center" colspan="4" rowspan="1"><bold>ILI Fitness Change Groups (METs change in first-year)</bold></td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" colspan="6" valign="bottom" rowspan="1"><hr/></td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"><bold>Overall</bold><break/><bold>DSE</bold></td><td align="center" rowspan="1" colspan="1"><bold>Loss/Stable</bold><break/><bold>(&#x0003c;0.5)</bold></td><td align="center" rowspan="1" colspan="1"><bold>Small Gain</bold><break/><bold>(0.5 to 1.0)</bold></td><td align="center" rowspan="1" colspan="1"><bold>Medium Gain</bold><break/><bold>(1.0 to 2.0)</bold></td><td align="center" rowspan="1" colspan="1"><bold>Large Gain</bold><break/><bold>(&#x02265;2.0)</bold></td><td align="center" rowspan="1" colspan="1"><bold>HR per SD fitness</bold><break/><bold>change</bold></td><td align="center" valign="top" rowspan="1" colspan="1"><bold>P value</bold></td></tr><tr><td align="center" colspan="8" valign="bottom" rowspan="1"><hr/></td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Secondary Outcome 1</bold></td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Events / person years</td><td align="center" rowspan="1" colspan="1">208 / 19521</td><td align="center" rowspan="1" colspan="1">104 / 8257</td><td align="center" rowspan="1" colspan="1">35 / 3172</td><td align="center" rowspan="1" colspan="1">39 / 4856</td><td align="center" rowspan="1" colspan="1">31 / 4312</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Crude rate/100 person years</td><td align="center" rowspan="1" colspan="1">1.07</td><td align="center" rowspan="1" colspan="1">1.26</td><td align="center" rowspan="1" colspan="1">1.10</td><td align="center" rowspan="1" colspan="1">0.80</td><td align="center" rowspan="1" colspan="1">0.72</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Unadjusted HR (95% C.I.)</td><td align="center" rowspan="1" colspan="1">1.0</td><td align="center" rowspan="1" colspan="1">1.20 (0.95 &#x02013; 1.52)</td><td align="center" rowspan="1" colspan="1">1.03 (0.72 &#x02013; 1.47)</td><td align="center" rowspan="1" colspan="1">0.75 (0.53 &#x02013; 1.05)</td><td align="center" rowspan="1" colspan="1">0.66 (0.45 &#x02013; 0.96)</td><td align="center" rowspan="1" colspan="1">0.83 (0.72 &#x02013; 0.97)</td><td align="center" rowspan="1" colspan="1">0.02</td></tr><tr><td align="left" rowspan="1" colspan="1">Adjusted HR<xref ref-type="table-fn" rid="TFN10">&#x001c2;</xref>(95% C.I.)</td><td align="center" rowspan="1" colspan="1">1.0</td><td align="center" rowspan="1" colspan="1">1.22 (0.96 &#x02013; 1.56)</td><td align="center" rowspan="1" colspan="1">1.04 (0.72 &#x02013; 1.51)</td><td align="center" rowspan="1" colspan="1">0.79 (0.55 &#x02013; 1.12)</td><td align="center" rowspan="1" colspan="1">0.69 (0.47 &#x02013; 1.03)</td><td align="center" rowspan="1" colspan="1">0.82 (0.70 &#x02013; 0.97)</td><td align="center" rowspan="1" colspan="1">0.02</td></tr><tr><td align="center" colspan="8" valign="bottom" rowspan="1"><hr/></td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Secondary Outcome 2</bold></td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Events / person years</td><td align="center" rowspan="1" colspan="1">385 / 19026</td><td align="center" rowspan="1" colspan="1">183 / 8025</td><td align="center" rowspan="1" colspan="1">69 / 3081</td><td align="center" rowspan="1" colspan="1">77 / 4744</td><td align="center" rowspan="1" colspan="1">72 / 4190</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Crude rate/100 person years</td><td align="center" rowspan="1" colspan="1">2.02</td><td align="center" rowspan="1" colspan="1">2.28</td><td align="center" rowspan="1" colspan="1">2.24</td><td align="center" rowspan="1" colspan="1">1.62</td><td align="center" rowspan="1" colspan="1">1.72</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Unadjusted HR (95% C.I.)</td><td align="center" rowspan="1" colspan="1">1.0</td><td align="center" rowspan="1" colspan="1">1.15 (0.97 &#x02013; 1.37)</td><td align="center" rowspan="1" colspan="1">1.09 (0.85 &#x02013; 1.41)</td><td align="center" rowspan="1" colspan="1">0.80 (0.62 &#x02013; 1.02)</td><td align="center" rowspan="1" colspan="1">0.84 (0.65 &#x02013; 1.08)</td><td align="center" rowspan="1" colspan="1">0.90 (0.81 &#x02013; 0.99)</td><td align="center" rowspan="1" colspan="1">0.047</td></tr><tr><td align="left" rowspan="1" colspan="1">Adjusted HR<xref ref-type="table-fn" rid="TFN10">&#x001c2;</xref>(95% C.I.)</td><td align="center" rowspan="1" colspan="1">1.0</td><td align="center" rowspan="1" colspan="1">1.16 (0.97 &#x02013; 1.39)</td><td align="center" rowspan="1" colspan="1">1.11 (0.85 &#x02013; 1.44)</td><td align="center" rowspan="1" colspan="1">0.79 (0.62 &#x02013; 1.02)</td><td align="center" rowspan="1" colspan="1">0.87 (0.67 &#x02013; 1.14)</td><td align="center" rowspan="1" colspan="1">0.90 (0.80 &#x02013; 1.01)</td><td align="center" rowspan="1" colspan="1">0.08</td></tr></tbody></table><table-wrap-foot><fn id="TFN10"><label>&#x001c2;</label><p id="P40">adjusted for sex, age, baseline weight(weight change models), baseline fitness (fitness change models), CVD history, insulin use, diabetes duration, smoking status, LDL, SBP, DBP. Secondary Outcome 1: (MI, stroke, CVD Death); Secondary Outcome 2: (non-fatal MI, stroke, hospitalized angina, CVD death, total mortality).</p></fn></table-wrap-foot></table-wrap><p id="P41"><bold><underline>Authors:</underline></bold> Edward W. Gregg, PhD; John M. Jakicic, PhD; George Blackburn, MD, PhD; Paul Bloomquist, MD; George A. Bray, MD; Timothy Church, MD; Jeanne M. Clark, MD, MPH; Mace Coday, PhD; Jeffrey M. Curtis, MD, MPH; Caitlin Egan, MS; Mary Evans, PhD; John P. Foreyt, PhD; Gary Foster, PhD; Siran Ghazarian, MD; Helen P. Hazuda, PhD; James O. Hill, PhD; Edward S. Horton, MD; Van S. Hubbard, MD; Robert W. Jeffery, PhD; Karen C. Johnson, MD, MPH; Steven E. Kahn, MB, ChB; Abbas E. Kitabchi, PhD, MD; William C. Knowler, MD; Andrea Kriska, PhD; Wei Lang, PhD; Cora E. Lewis, MD, MSPH; Maria G. Montez, RN, MSHP, CDE; David M. Nathan, MD; Rebecca H. Neiberg, MS; Jennifer Patricio, MS; Anne Peters, MD; Xavier Pi-Sunyer, MD; Henry Pownall, PhD; Bruce Redmon, MD; Judith Regensteiner, PhD; Jack Rejeski, PhD; Paul M. Ribisl, PhD; Monika Safford, MD; Kerry Stewart, EdD; Dace Trence, MD; Thomas A. Wadden, PhD; Rena R. Wing, PhD; Susan Z. Yanovski, MD</p><p id="P42"><underline>Writing Group</underline>: Edward Gregg, Beth Lewis, Judy Regensteiner, Xavier Pi-Sunyer, John Jakicic, Rena Wing, Jeff Curtis, Sue Yanovski, Mary Evans, Wei Lang, Rebecca Neiberg, Paul Ribisl</p><p id="P43"><bold>Appendix: Look AHEAD Research Group at End of Intervention</bold></p><p id="P44">Updated 08/11/2015</p><p id="P45"><bold><underline>Clinical Sites</underline></bold></p><p id="P46"><underline>The Johns Hopkins University</underline> Frederick L. Brancati, MD, MHS<xref ref-type="other" rid="P82">1</xref>; Jeanne M. Clark, MD, MPH (Co-Principal Investigators); Lee Swartz<xref ref-type="other" rid="P83">2</xref>; Jeanne Charleston, RN<xref ref-type="other" rid="P84">3</xref>; Lawrence Cheskin, MD<xref ref-type="other" rid="P84">3</xref>; Kerry Stewart, EdD<xref ref-type="other" rid="P84">3</xref>; Richard Rubin, PhD<xref ref-type="other" rid="P84">3</xref>; Jean Arceci, RN; Susanne Danus; David Bolen; Danielle Diggins; Sara Evans; Mia Johnson; Joyce Lambert; Sarah Longenecker; Kathy Michalski, RD; Dawn Jiggetts; Chanchai Sapun; Maria Sowers; Kathy Tyler</p><p id="P47"><underline>Pennington Biomedical Research Center</underline> George A. Bray, MD<xref ref-type="other" rid="P82">1</xref>; Allison Strate, RN<xref ref-type="other" rid="P83">2</xref>; Frank L. Greenway, MD<xref ref-type="other" rid="P84">3</xref>; Donna H. Ryan, MD<xref ref-type="other" rid="P84">3</xref>; Donald Williamson, PhD<xref ref-type="other" rid="P84">3</xref>; Timothy Church, MD<xref ref-type="other" rid="P84">3</xref>; Catherine Champagne, PhD, RD; Valerie Myers, PhD; Jennifer Arceneaux, RN; Kristi Rau; Michelle Begnaud, LDN, RD, CDE; Barbara Cerniauskas, LDN, RD, CDE; Crystal Duncan, LPN; Helen Guay, LDN, LPC, RD; Carolyn Johnson, LPN, Lisa Jones; Kim Landry; Missy Lingle; Jennifer Perault; Cindy Puckett; Marisa Smith; Lauren Cox; Monica Lockett, LPN</p><p id="P48"><underline>The University of Alabama at Birmingham</underline> Cora E. Lewis, MD, MSPH<xref ref-type="other" rid="P82">1</xref>; Sheikilya Thomas, MPH<xref ref-type="other" rid="P83">2</xref>; Monika Safford, MD<xref ref-type="other" rid="P84">3</xref>; Stephen Glasser, MD<xref ref-type="other" rid="P84">3</xref>; Vicki DiLillo, PhD<xref ref-type="other" rid="P84">3</xref>; Charlotte Bragg, MS, RD, LD; Amy Dobelstein; Sara Hannum, MA; Anne Hubbell, MS; Jane King, MLT; DeLavallade Lee; Andre Morgan; L. Christie Oden; Janet Wallace, MS; Cathy Roche, PhD, RN, BSN; Jackie Roche; Janet Turman</p><p id="P49"><underline>Harvard Center</underline></p><p id="P50"><italic>Massachusetts General Hospital</italic>. David M. Nathan, MD<xref ref-type="other" rid="P82">1</xref>; Enrico Cagliero, MD<xref ref-type="other" rid="P84">3</xref>; Kathryn Hayward, MD<xref ref-type="other" rid="P84">3</xref>; Heather Turgeon, RN, BS, CDE<xref ref-type="other" rid="P83">2</xref>; Valerie Goldman, MS, RD<xref ref-type="other" rid="P83">2</xref>; Linda Delahanty, MS, RD<xref ref-type="other" rid="P84">3</xref>; Ellen Anderson, MS, RD<xref ref-type="other" rid="P84">3</xref>; Laurie Bissett, MS, RD; Virginia Harlan, MSW; Theresa Michel, DPT, DSc, CCS; Mary Larkin, RN; Christine Stevens, RN</p><p id="P51"><italic>Joslin Diabetes Center</italic>: Edward S. Horton, MD<xref ref-type="other" rid="P82">1</xref>; Sharon D. Jackson, MS, RD, CDE<xref ref-type="other" rid="P83">2</xref>; Osama Hamdy, MD, PhD<xref ref-type="other" rid="P84">3</xref>; A. Enrique Caballero, MD<xref ref-type="other" rid="P84">3</xref>; Sarah Bain, BS; Elizabeth Bovaird, BSN, RN; Barbara Fargnoli, MS, RD; Jeanne Spellman, BS, RD; Kari Galuski, RN; Ann Goebel-Fabbri, PhD; Lori Lambert, MS, RD; Sarah Ledbury, MEd, RD; Maureen Malloy, BS; Kerry Ovalle, MS, RCEP, CDE</p><p id="P52"><italic>Beth Israel Deaconess Medical Center</italic>: George Blackburn, MD, PhD<xref ref-type="other" rid="P82">1</xref>; Christos Mantzoros, MD, DSc<xref ref-type="other" rid="P84">3</xref>; Ann McNamara, RN; Kristina Spellman, RD</p><p id="P53"><underline>University of Colorado Anschutz Medical Campus</underline> James O. Hill, PhD<xref ref-type="other" rid="P82">1</xref>; Marsha Miller, MS RD<xref ref-type="other" rid="P83">2</xref>; Holly Wyatt, MD<xref ref-type="other" rid="P84">3</xref>, Brent Van Dorsten, PhD<xref ref-type="other" rid="P84">3</xref>; Judith Regensteiner, PhD<xref ref-type="other" rid="P84">3</xref>; Debbie Bochert; Ligia Coelho, BS; Paulette Cohrs, RN, BSN; Susan Green; April Hamilton, BS, CCRC; Jere Hamilton, BA; Eugene Leshchinskiy; Loretta Rome, TRS; Terra Thompson, BA; Kirstie Craul, RD, CDE; Cecilia Wang, MD</p><p id="P54"><underline>Baylor College of Medicine</underline> John P. Foreyt, PhD<xref ref-type="other" rid="P82">1</xref>; Rebecca S. Reeves, DrPH, RD<xref ref-type="other" rid="P83">2</xref>; Molly Gee, MEd, RD<xref ref-type="other" rid="P83">2</xref>; Henry Pownall, PhD<xref ref-type="other" rid="P84">3</xref>; Ashok Balasubramanyam, MBBS<xref ref-type="other" rid="P84">3</xref>; Chu-Huang Chen, MD, PhD<xref ref-type="other" rid="P84">3</xref>; Peter Jones, MD<xref ref-type="other" rid="P84">3</xref>; Michele Burrington, RD, RN; Allyson Clark Gardner, MS, RD; Sharon Griggs; Michelle Hamilton; Veronica Holley; Sarah Lee; Sarah Lane Liscum, RN, MPH; Susan Cantu-Lumbreras; Julieta Palencia, RN; Jennifer Schmidt; Jayne Thomas, RD; Carolyn White</p><p id="P55"><underline>The University of Tennessee Health Science Center</underline></p><p id="P56"><italic>University of Tennessee East.</italic> Karen C. Johnson, MD, MPH<xref ref-type="other" rid="P82">1</xref>; Carolyn Gresham, RN<xref ref-type="other" rid="P83">2</xref>; Mace Coday, PhD; Lisa Jones, RN; Lynne Lichtermann, RN, BSN; J. Lee Taylor, MEd, MBA; Beate Griffin, RN; Donna Valenski</p><p id="P57"><italic>University of Tennessee Downtown.</italic> Abbas E. Kitabchi, PhD, MD<xref ref-type="other" rid="P82">1</xref>; Ebenezer Nyenwe, MD<xref ref-type="other" rid="P84">3</xref>; Helen Lambeth, RN, BSN<xref ref-type="other" rid="P83">2</xref>; Moana Mosby, RN; Amy Brewer, MS, RD, LDN; Debra Clark, LPN; Andrea Crisler, MT; Gracie Cunningham; Debra Force, MS, RD, LDN; Donna Green, RN; Robert Kores, PhD; Renate Rosenthal, PhD; Elizabeth Smith, MS, RD, LDN</p><p id="P58">University of Minnesota Robert W. Jeffery, PhD<xref ref-type="other" rid="P82">1</xref>; Tricia Skarphol, MA<xref ref-type="other" rid="P83">2</xref>; Carolyn Thorson, CCRP<xref ref-type="other" rid="P83">2</xref>; John P. Bantle, MD<xref ref-type="other" rid="P84">3</xref>; J. Bruce Redmon, MD<xref ref-type="other" rid="P84">3</xref>; Richard S. Crow, MD<xref ref-type="other" rid="P84">3</xref>; Kerrin Brelje, MPH, RD; Carolyne Campbell; Lisa Hoelscher, MPH, RD, CHES; Melanie Jaeb, MPH, RD; LaDonna James; Patti Laqua, BS, RD; Vicki A. Maddy, BS, RD; Therese Ockenden, RN; Birgitta I. Rice, MS, RPh, CHES; Ann D. Tucker, BA; Mary Susan Voeller, BA; Cara Walcheck, BS, RD</p><p id="P59"><underline>St. Luke&#x02019;s Roosevelt Hospital Center</underline> Xavier Pi-Sunyer, MD<xref ref-type="other" rid="P82">1</xref>; Jennifer Patricio, MS<xref ref-type="other" rid="P83">2</xref>; Carmen Pal, MD<xref ref-type="other" rid="P84">3</xref>; Lynn Allen, MD; Janet Crane, MA, RD, CDN; Lolline Chong, BS, RD; Diane Hirsch, RNC, MS, CDE; Mary Anne Holowaty, MS, CN; Michelle Horowitz, MS, RD</p><p id="P60"><underline>University of Pennsylvania</underline> Thomas A. Wadden, PhD <xref ref-type="other" rid="P82">1</xref>; Barbara J. Maschak-Carey, MSN, CDE <xref ref-type="other" rid="P83">2</xref>; Robert I. Berkowitz, MD <xref ref-type="other" rid="P84">3</xref>; Seth Braunstein, MD, PhD <xref ref-type="other" rid="P84">3</xref>; Gary Foster, PhD <xref ref-type="other" rid="P84">3</xref>; Henry Glick, PhD <xref ref-type="other" rid="P84">3</xref>; Shiriki Kumanyika, PhD, RD, MPH <xref ref-type="other" rid="P84">3</xref>; Stanley S. Schwartz, MD <xref ref-type="other" rid="P84">3</xref> ; Yuliis Bell, BA; Raymond Carvajal, PsyD; Helen Chomentowski; Renee Davenport; Anthony Fabricatore, PhD; Lucy Faulconbridge, PhD; Louise Hesson, MSN, CRNP; Nayyar Iqbal, MD; Robert Kuehnel, PhD; Patricia Lipschutz, MSN; Monica Mullen, RD, MPH</p><p id="P61"><underline>University of Pittsburgh</underline> John M. Jakicic, PhD<xref ref-type="other" rid="P82">1</xref>; David E. Kelley, MD<xref ref-type="other" rid="P82">1</xref>; Jacqueline Wesche-Thobaben, RN, BSN, CDE<xref ref-type="other" rid="P83">2</xref>; Lewis H. Kuller, MD, DrPH<xref ref-type="other" rid="P84">3</xref>; Andrea Kriska, PhD<xref ref-type="other" rid="P84">3</xref>; Amy D. Rickman, PhD, RD, LDN<xref ref-type="other" rid="P84">3</xref>; Lin Ewing, PhD, RN<xref ref-type="other" rid="P84">3</xref>; Mary Korytkowski, MD<xref ref-type="other" rid="P84">3</xref>; Daniel Edmundowicz, MD<xref ref-type="other" rid="P84">3</xref>; Rose Salata, MD<xref ref-type="other" rid="P84">3</xref>; Rebecca Danchenko, BS; Tammy DeBruce; Barbara Elnyczky; David O. Garcia, MS; Patricia H. Harper, MS, RD, LDN; Susan Harrier, BS; Dianne Heidingsfelder, MS, RD, CDE, LDN; Diane Ives, MPH; Juliet Mancino, MS, RD, CDE, LDN; Lisa Martich, MS, RD; Tracey Y. Murray, BS; Karen Quirin; Joan R. Ritchea; Susan Copelli, BS, CTR</p><p id="P62"><underline>The Miriam Hospital/Brown Medical School</underline> Rena R. Wing, PhD<xref ref-type="other" rid="P82">1</xref>; Renee Bright, MS<xref ref-type="other" rid="P83">2</xref>; Vincent Pera, MD<xref ref-type="other" rid="P84">3</xref>; John Jakicic, PhD<xref ref-type="other" rid="P84">3</xref>; Deborah Tate, PhD<xref ref-type="other" rid="P84">3</xref>; Amy Gorin, PhD<xref ref-type="other" rid="P84">3</xref>; Kara Gallagher, PhD<xref ref-type="other" rid="P84">3</xref>; Amy Bach, PhD; Barbara Bancroft, RN, MS; Anna Bertorelli, MBA, RD; Richard Carey, BS; Tatum Charron, BS; Heather Chenot, MS; Kimberley Chula-Maguire, MS; Pamela Coward, MS, RD; Lisa Cronkite, BS; Julie Currin, MD; Maureen Daly, RN; Caitlin Egan, MS; Erica Ferguson, BS, RD; Linda Foss, MPH; Jennifer Gauvin, BS; Don Kieffer, PhD; Lauren Lessard, BS; Deborah Maier, MS; JP Massaro, BS; Tammy Monk, MS; Rob Nicholson, PhD; Erin Patterson, BS; Suzanne Phelan, PhD; Hollie Raynor, PhD, RD; Douglas Raynor, PhD; Natalie Robinson, MS, RD; Deborah Robles; Jane Tavares, BS</p><p id="P63"><underline>The University of Texas Health Science Center at San Antonio</underline> Steven M. Haffner, MD<xref ref-type="other" rid="P82">1</xref>; Helen P. Hazuda, PhD1; Maria G. Montez, RN, MSHP, CDE<xref ref-type="other" rid="P83">2</xref>; Carlos Lorenzo, MD<xref ref-type="other" rid="P84">3</xref>; Charles F. Coleman, MS, RD; Domingo Granado, RN; Kathy Hathaway, MS, RD; Juan Carlos Isaac, RC, BSN; Nora Ramirez, RN, BSN</p><p id="P64"><underline>VA Puget Sound Health Care System / University of Washington</underline> Steven E. Kahn, MB, ChB<xref ref-type="other" rid="P82">1</xref>; Anne Murillo, BS<xref ref-type="other" rid="P83">2</xref>; Robert Knopp, MD<xref ref-type="other" rid="P84">3</xref>; Edward Lipkin, MD, PhD<xref ref-type="other" rid="P84">3</xref>; Dace Trence, MD<xref ref-type="other" rid="P84">3</xref>; Elaine Tsai, MD<xref ref-type="other" rid="P84">3</xref>; Basma Fattaleh, BA; Diane Greenberg, PhD; Brenda Montgomery, RN, MS, CDE; Ivy Morgan-Taggart; Betty Ann Richmond, MEd; Jolanta Socha, BS; April Thomas, MPH, RD; Alan Wesley, BA; Diane Wheeler, RD, CDE</p><p id="P65"><underline>Southwestern American Indian Center, Phoenix, Arizona and Shiprock, New Mexico</underline> William C. Knowler, MD, DrPH<xref ref-type="other" rid="P82">1</xref>; Paula Bolin, RN, MC<xref ref-type="other" rid="P83">2</xref>; Tina Killean, BS<xref ref-type="other" rid="P83">2</xref>; Cathy Manus, LPN<xref ref-type="other" rid="P84">3</xref>; Jonathan Krakoff, MD<xref ref-type="other" rid="P84">3</xref>; Jeffrey M. Curtis, MD, MPH<xref ref-type="other" rid="P84">3</xref>; Sara Michaels, MD<xref ref-type="other" rid="P84">3</xref>; Paul Bloomquist, MD<xref ref-type="other" rid="P84">3</xref>; Peter H. Bennett, MB, FRCP<xref ref-type="other" rid="P84">3</xref>; Bernadita Fallis RN, RHIT, CCS; Diane F. Hollowbreast; Ruby Johnson; Maria Meacham, BSN, RN, CDE; Christina Morris, BA; Julie Nelson, RD; Carol Percy, RN; Patricia Poorthunder; Sandra Sangster; Leigh A. Shovestull, RD, CDE; Miranda Smart; Janelia Smiley; Teddy Thomas, BS; Katie Toledo, MS, LPC</p><p id="P66"><underline>University of Southern California</underline> Anne Peters, MD<xref ref-type="other" rid="P82">1</xref>; Siran Ghazarian, MD<xref ref-type="other" rid="P83">2</xref>; Elizabeth Beale, MD<xref ref-type="other" rid="P84">3</xref>; Kati Konersman, RD, CDE; Brenda Quintero-Varela; Edgar Ramirez; Gabriela Rios, RD; Gabriela Rodriguez, MA; Valerie Ruelas MSW, LCSW; Sara Serafin-Dokhan; Martha Walker, RD</p><p id="P67"><underline><bold>Coordinating Center</bold></underline></p><p id="P68"><underline>Wake Forest University</underline> Mark A. Espeland, PhD<xref ref-type="other" rid="P82">1</xref>; Judy L. Bahnson, BA, CCRP<xref ref-type="other" rid="P84">3</xref>; Lynne E. Wagenknecht, DrPH<xref ref-type="other" rid="P84">3</xref>; David Reboussin, PhD<xref ref-type="other" rid="P84">3</xref>; W. Jack Rejeski, PhD<xref ref-type="other" rid="P84">3</xref>; Alain G. Bertoni, MD, MPH<xref ref-type="other" rid="P84">3</xref>; Wei Lang, PhD<xref ref-type="other" rid="P84">3</xref>; Michael S. Lawlor, PhD<xref ref-type="other" rid="P84">3</xref>; David Lefkowitz, MD<xref ref-type="other" rid="P84">3</xref>; Gary D. Miller, PhD<xref ref-type="other" rid="P84">3</xref>; Patrick S. Reynolds, MD<xref ref-type="other" rid="P84">3</xref>; Paul M. Ribisl, PhD<xref ref-type="other" rid="P84">3</xref>; Mara Vitolins, DrPH<xref ref-type="other" rid="P84">3</xref>; Daniel Beavers, PhD<xref ref-type="other" rid="P84">3</xref>; Haiying Chen, PhD, MM<xref ref-type="other" rid="P84">3</xref>; Dalane Kitzman, MD<xref ref-type="other" rid="P84">3</xref>; Delia S. West, PhD<xref ref-type="other" rid="P84">3</xref>; Lawrence M. Friedman, MD<xref ref-type="other" rid="P84">3</xref>; Ron Prineas, MD<xref ref-type="other" rid="P84">3</xref>; Tandaw Samdarshi, MD<xref ref-type="other" rid="P84">3</xref>;Kathy M. Dotson, BA<xref ref-type="other" rid="P83">2</xref>; Amelia Hodges, BS, CCRP<xref ref-type="other" rid="P83">2</xref>; Dominique Limprevil-Divers, MA, MEd<xref ref-type="other" rid="P83">2</xref>; Karen Wall<xref ref-type="other" rid="P83">2</xref>; Carrie C. Williams, MA, CCRP<xref ref-type="other" rid="P83">2</xref>; Andrea Anderson, MS; Jerry M. Barnes, MA; Mary Barr; Tara D. Beckner; Cralen Davis, MS; Thania Del Valle-Fagan, MD; Tamika Earl, Melanie Franks, BBA; Candace Goode; Jason Griffin, BS; Lea Harvin, BS; Mary A. Hontz, BA; Sarah A. Gaussoin, MS; Don G. Hire, BS; Patricia Hogan, MS; Mark King, BS; Kathy Lane, BS; Rebecca H. Neiberg, MS; Julia T. Rushing, MS; Valery S. Effoe, MD, MS; Michael P. Walkup, MS; Terri Windham</p><p id="P69"><underline><bold>Central Resources Centers</bold></underline></p><p id="P70"><underline>DXA Reading Center, University of California at San Francisco</underline> Michael Nevitt, PhD<xref ref-type="other" rid="P82">1</xref>; Ann Schwartz, PhD<xref ref-type="other" rid="P83">2</xref>; John Shepherd, PhD<xref ref-type="other" rid="P84">3</xref>; Michaela Rahorst; Lisa Palermo, MS, MA; Susan Ewing, MS; Cynthia Hayashi; Jason Maeda, MPH</p><p id="P71"><underline>Central Laboratory, Northwest Lipid Metabolism and Diabetes Research Laboratories</underline> Santica M. Marcovina, PhD, ScD<xref ref-type="other" rid="P82">1</xref>; Jessica Hurting<xref ref-type="other" rid="P83">2</xref>; John J. Albers, PhD<xref ref-type="other" rid="P84">3</xref>, Vinod Gaur, PhD<sup>4</sup></p><p id="P72"><underline>ECG Reading Center, EPICARE, Wake Forest University School of Medicine</underline></p><p id="P73">Elsayed Z. Soliman MD, MSc, MS<xref ref-type="other" rid="P82">1</xref>; Charles Campbell <xref ref-type="other" rid="P83">2</xref>; Zhu-Ming Zhang, MD<xref ref-type="other" rid="P84">3</xref>; Mary Barr; Susan Hensley; Julie Hu; Lisa Keasler; Yabing Li, MD</p><p id="P74"><underline>Diet Assessment Center, University of South Carolina, Arnold School of Public Health, Center for Research in Nutrition and Health Disparities</underline></p><p id="P75">Elizabeth J Mayer-Davis, PhD<xref ref-type="other" rid="P82">1</xref>; Robert Moran, PhD<xref ref-type="other" rid="P82">1</xref></p><p id="P76"><underline>Hall-Foushee Communications, Inc.</underline></p><p id="P77">Richard Foushee, PhD; Nancy J. Hall, MA</p><p id="P78"><underline><bold>Federal Sponsors</bold></underline></p><p id="P79"><underline>National Institute of Diabetes and Digestive and Kidney Diseases</underline> Mary Evans, PhD; Barbara Harrison, MS; Van S. Hubbard, MD, PhD; Susan Z. Yanovski, MD</p><p id="P80"><underline>National Heart, Lung, and Blood Institute</underline> Lawton S. Cooper, MD, MPH; Peter Kaufman, PhD, FABMR; Mario Stylianou, PhD</p><p id="P81"><underline>Centers for Disease Control and Prevention</underline> Edward W. Gregg, PhD; Ping Zhang, PhD</p><p id="P82">1 Principal Investigator</p><p id="P83">2 Program Coordinator</p><p id="P84">3 Co-Investigator</p><p id="P85">All other Look AHEAD staffs are listed alphabetically by site.</p></app></app-group><ref-list><title>REFERENCES</title><ref id="R1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Flegal</surname><given-names>KM</given-names></name><name><surname>Kit</surname><given-names>BK</given-names></name><name><surname>Orpana</surname><given-names>H</given-names></name><name><surname>Graubard</surname><given-names>BI</given-names></name></person-group><article-title>Association of all-cause mortality with overweight and obesity using standard body mass index categories: a systematic review and meta-analysis</article-title><source>Jama</source><year>2013</year><volume>309</volume><issue>1</issue><fpage>71</fpage><lpage>82</lpage><pub-id pub-id-type="pmid">23280227</pub-id></element-citation></ref><ref id="R2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Powell</surname><given-names>KE</given-names></name><name><surname>Thompson</surname><given-names>PD</given-names></name><name><surname>Caspersen</surname><given-names>CJ</given-names></name><name><surname>Kendrick</surname><given-names>JS</given-names></name></person-group><article-title>Physical activity and the incidence of coronary heart disease</article-title><source>Annual review of public health</source><year>1987</year><volume>8</volume><fpage>253</fpage><lpage>287</lpage></element-citation></ref><ref id="R3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Blair</surname><given-names>SN</given-names></name><name><surname>Kampert</surname><given-names>JB</given-names></name><name><surname>Kohl</surname><given-names>HW</given-names><suffix>3rd</suffix></name><name><surname>Barlow</surname><given-names>CE</given-names></name><name><surname>Macera</surname><given-names>CA</given-names></name><name><surname>Paffenbarger</surname><given-names>RS</given-names><suffix>Jr</suffix></name><etal/></person-group><article-title>Influences of cardiorespiratory fitness and other precursors on cardiovascular disease and all-cause mortality in men and women</article-title><source>JAMA</source><year>1996</year><volume>276</volume><issue>3</issue><fpage>205</fpage><lpage>210</lpage><pub-id pub-id-type="pmid">8667564</pub-id></element-citation></ref><ref id="R4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stevens</surname><given-names>VJ</given-names></name><name><surname>Obarzanek</surname><given-names>E</given-names></name><name><surname>Cook</surname><given-names>NR</given-names></name><name><surname>Lee</surname><given-names>IM</given-names></name><name><surname>Appel</surname><given-names>LJ</given-names></name><name><surname>Smith</surname><given-names>WD</given-names></name><etal/></person-group><article-title>Long-term weight loss and changes in blood pressure: results of the Trials of Hypertension Prevention, phase II</article-title><source>Ann Intern Med</source><year>2001</year><volume>134</volume><issue>1</issue><fpage>1</fpage><lpage>11</lpage><pub-id pub-id-type="pmid">11187414</pub-id></element-citation></ref><ref id="R5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boule</surname><given-names>NG</given-names></name><name><surname>Haddad</surname><given-names>E</given-names></name><name><surname>Kenny</surname><given-names>GP</given-names></name><name><surname>Wells</surname><given-names>GA</given-names></name><name><surname>Sigal</surname><given-names>RJ</given-names></name></person-group><article-title>Effects of exercise on glycemic control and body mass in type 2 diabetes mellitus: a meta-analysis of controlled clinical trials</article-title><source>JAMA</source><year>2001</year><volume>286</volume><issue>10</issue><fpage>1218</fpage><lpage>1227</lpage><pub-id pub-id-type="pmid">11559268</pub-id></element-citation></ref><ref id="R6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Knowler</surname><given-names>WC</given-names></name><name><surname>Barrett-Connor</surname><given-names>E</given-names></name><name><surname>Fowler</surname><given-names>SE</given-names></name><name><surname>Hamman</surname><given-names>RF</given-names></name><name><surname>Lachin</surname><given-names>JM</given-names></name><name><surname>Walker</surname><given-names>EA</given-names></name><etal/></person-group><article-title>Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin</article-title><source>N Engl J Med</source><year>2002</year><volume>346</volume><issue>6</issue><fpage>393</fpage><lpage>403</lpage><pub-id pub-id-type="pmid">11832527</pub-id></element-citation></ref><ref id="R7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tuomilehto</surname><given-names>J</given-names></name><name><surname>Lindstrom</surname><given-names>J</given-names></name><name><surname>Eriksson</surname><given-names>JG</given-names></name><name><surname>Valle</surname><given-names>TT</given-names></name><name><surname>Hamalainen</surname><given-names>H</given-names></name><name><surname>Ilanne-Parikka</surname><given-names>P</given-names></name><etal/></person-group><article-title>Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance</article-title><source>N Engl J Med</source><year>2001</year><volume>344</volume><issue>18</issue><fpage>1343</fpage><lpage>1350</lpage><pub-id pub-id-type="pmid">11333990</pub-id></element-citation></ref><ref id="R8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aucott</surname><given-names>L</given-names></name><name><surname>Gray</surname><given-names>D</given-names></name><name><surname>Rothnie</surname><given-names>H</given-names></name><name><surname>Thapa</surname><given-names>M</given-names></name><name><surname>Waweru</surname><given-names>C</given-names></name></person-group><article-title>Effects of lifestyle interventions and long-term weight loss on lipid outcomes - a systematic review</article-title><source>Obes Rev</source><year>2011</year><volume>12</volume><issue>5</issue><fpage>e412</fpage><lpage>e425</lpage><pub-id pub-id-type="pmid">21371252</pub-id></element-citation></ref><ref id="R9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wing</surname><given-names>RR</given-names></name><name><surname>Bolin</surname><given-names>P</given-names></name><name><surname>Brancati</surname><given-names>FL</given-names></name><name><surname>Bray</surname><given-names>GA</given-names></name><name><surname>Clark</surname><given-names>JM</given-names></name><name><surname>Coday</surname><given-names>M</given-names></name><etal/></person-group><article-title>Cardiovascular effects of intensive lifestyle intervention in type 2 diabetes</article-title><source>The New England journal of medicine</source><year>2013</year><volume>369</volume><issue>2</issue><fpage>145</fpage><lpage>154</lpage><pub-id pub-id-type="pmid">23796131</pub-id></element-citation></ref><ref id="R10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Harrington</surname><given-names>M</given-names></name><name><surname>Gibson</surname><given-names>S</given-names></name><name><surname>Cottrell</surname><given-names>RC</given-names></name></person-group><article-title>A review and meta-analysis of the effect of weight loss on all-cause mortality risk</article-title><source>Nutr Res Rev</source><year>2009</year><volume>22</volume><issue>1</issue><fpage>93</fpage><lpage>108</lpage><pub-id pub-id-type="pmid">19555520</pub-id></element-citation></ref><ref id="R11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rejeski</surname><given-names>WJ</given-names></name><name><surname>Ip</surname><given-names>EH</given-names></name><name><surname>Bertoni</surname><given-names>AG</given-names></name><name><surname>Bray</surname><given-names>GA</given-names></name><name><surname>Evans</surname><given-names>G</given-names></name><name><surname>Gregg</surname><given-names>EW</given-names></name><etal/></person-group><article-title>Lifestyle change and mobility in obese adults with type 2 diabetes</article-title><source>N Engl J Med</source><year>2012</year><volume>366</volume><issue>13</issue><fpage>1209</fpage><lpage>1217</lpage><pub-id pub-id-type="pmid">22455415</pub-id></element-citation></ref><ref id="R12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wing</surname><given-names>RR</given-names></name><name><surname>Lang</surname><given-names>W</given-names></name><name><surname>Wadden</surname><given-names>TA</given-names></name><name><surname>Safford</surname><given-names>M</given-names></name><name><surname>Knowler</surname><given-names>WC</given-names></name><name><surname>Bertoni</surname><given-names>AG</given-names></name><etal/></person-group><article-title>Benefits of modest weight loss in improving cardiovascular risk factors in overweight and obese individuals with type 2 diabetes. diabetes care</article-title><year>2011</year><volume>34</volume><issue>7</issue><fpage>1481</fpage><lpage>1486</lpage></element-citation></ref><ref id="R13"><label>13</label><element-citation publication-type="journal"><article-title>Effect of a long-term behavioural weight loss intervention on nephropathy in overweight or obese adults with type 2 diabetes: a secondary analysis of the Look AHEAD randomised clinical trial</article-title><source>Lancet Diabetes Endocrinol</source><year>2014</year><volume>2</volume><issue>10</issue><fpage>801</fpage><lpage>809</lpage><pub-id pub-id-type="pmid">25127483</pub-id></element-citation></ref><ref id="R14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kruger</surname><given-names>J</given-names></name><name><surname>Galuska</surname><given-names>DA</given-names></name><name><surname>Serdula</surname><given-names>MK</given-names></name><name><surname>Jones</surname><given-names>DA</given-names></name></person-group><article-title>Attempting to lose weight: specific practices among U.S. adults</article-title><source>Am J Prev Med</source><year>2004</year><volume>26</volume><issue>5</issue><fpage>402</fpage><lpage>406</lpage><pub-id pub-id-type="pmid">15165656</pub-id></element-citation></ref><ref id="R15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wadden</surname><given-names>TA</given-names></name><name><surname>Butryn</surname><given-names>ML</given-names></name><name><surname>Hong</surname><given-names>PS</given-names></name><name><surname>Tsai</surname><given-names>AG</given-names></name></person-group><article-title>Behavioral treatment of obesity in patients encountered in primary care settings: a systematic review</article-title><source>JAMA</source><year>2014</year><volume>312</volume><issue>17</issue><fpage>1779</fpage><lpage>1791</lpage><pub-id pub-id-type="pmid">25369490</pub-id></element-citation></ref><ref id="R16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wadden</surname><given-names>TA</given-names></name><name><surname>Neiberg</surname><given-names>RH</given-names></name><name><surname>Wing</surname><given-names>RR</given-names></name><name><surname>Clark</surname><given-names>JM</given-names></name><name><surname>Delahanty</surname><given-names>LM</given-names></name><name><surname>Hill</surname><given-names>JO</given-names></name><etal/></person-group><article-title>Four-year weight losses in the Look AHEAD study: factors associated with long-term success</article-title><source>Obesity (Silver Spring, Md)</source><year>2011</year><volume>19</volume><issue>10</issue><fpage>1987</fpage><lpage>1998</lpage></element-citation></ref><ref id="R17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ryan</surname><given-names>DH</given-names></name><name><surname>Espeland</surname><given-names>MA</given-names></name><name><surname>Foster</surname><given-names>GD</given-names></name><name><surname>Haffner</surname><given-names>SM</given-names></name><name><surname>Hubbard</surname><given-names>VS</given-names></name><name><surname>Johnson</surname><given-names>KC</given-names></name><etal/></person-group><article-title>Look AHEAD (Action for Health in Diabetes): design and methods for a clinical trial of weight loss for the prevention of cardiovascular disease in type 2 diabetes</article-title><source>Control Clin Trials</source><year>2003</year><volume>24</volume><issue>5</issue><fpage>610</fpage><lpage>628</lpage><pub-id pub-id-type="pmid">14500058</pub-id></element-citation></ref><ref id="R18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wadden</surname><given-names>TA</given-names></name><name><surname>West</surname><given-names>DS</given-names></name><name><surname>Delahanty</surname><given-names>L</given-names></name><name><surname>Jakicic</surname><given-names>J</given-names></name><name><surname>Rejeski</surname><given-names>J</given-names></name><name><surname>Williamson</surname><given-names>D</given-names></name><etal/></person-group><article-title>The Look AHEAD study: a description of the lifestyle intervention and the evidence supporting it</article-title><source>Obesity (Silver Spring)</source><year>2006</year><volume>14</volume><issue>5</issue><fpage>737</fpage><lpage>752</lpage><pub-id pub-id-type="pmid">16855180</pub-id></element-citation></ref><ref id="R19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wesche-Thobaben</surname><given-names>JA</given-names></name></person-group><article-title>The development and description of the comparison group in the Look AHEAD trial</article-title><source>Clin Trials</source><year>2011</year><volume>8</volume><issue>3</issue><fpage>320</fpage><lpage>329</lpage><pub-id pub-id-type="pmid">21730080</pub-id></element-citation></ref><ref id="R20"><label>20</label><element-citation publication-type="book"><collab>Medicine ACoS</collab><source>ACSM's Guidelines for Exercise Testing and Prescrtiption</source><year>2009</year><volume>2009</volume><edition>8th</edition><publisher-loc>Philadelphia</publisher-loc><publisher-name>Wolters Kluwer / Lippincott Williams and Wilkins</publisher-name></element-citation></ref><ref id="R21"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jakicic</surname><given-names>JM</given-names></name><name><surname>Jaramillo</surname><given-names>SA</given-names></name><name><surname>Balasubramanyam</surname><given-names>A</given-names></name><name><surname>Bancroft</surname><given-names>B</given-names></name><name><surname>Curtis</surname><given-names>JM</given-names></name><name><surname>Mathews</surname><given-names>A</given-names></name><etal/></person-group><article-title>Effect of a lifestyle intervention on change in cardiorespiratory fitness in adults with type 2 diabetes: results from the Look AHEAD Study</article-title><source>Int J Obes (Lond)</source><year>2009</year><volume>33</volume><issue>3</issue><fpage>305</fpage><lpage>316</lpage><pub-id pub-id-type="pmid">19153582</pub-id></element-citation></ref><ref id="R22"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>G</given-names></name><name><surname>Zhang</surname><given-names>P</given-names></name><name><surname>Wang</surname><given-names>J</given-names></name><name><surname>An</surname><given-names>Y</given-names></name><name><surname>Gong</surname><given-names>Q</given-names></name><name><surname>Gregg</surname><given-names>EW</given-names></name><etal/></person-group><article-title>Cardiovascular mortality, all-cause mortality, and diabetes incidence after lifestyle intervention for people with impaired glucose tolerance in the Da Qing Diabetes Prevention Study: a 23-year follow-up study</article-title><source>Lancet Diabetes Endocrinol</source><year>2014</year></element-citation></ref><ref id="R23"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Estruch</surname><given-names>R</given-names></name><name><surname>Ros</surname><given-names>E</given-names></name><name><surname>Salas-Salvado</surname><given-names>J</given-names></name><name><surname>Covas</surname><given-names>MI</given-names></name><name><surname>Corella</surname><given-names>D</given-names></name><name><surname>Aros</surname><given-names>F</given-names></name><etal/></person-group><article-title>Primary prevention of cardiovascular disease with a Mediterranean diet</article-title><source>The New England journal of medicine</source><year>2013</year><volume>368</volume><issue>14</issue><fpage>1279</fpage><lpage>1290</lpage><pub-id pub-id-type="pmid">23432189</pub-id></element-citation></ref><ref id="R24"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Avins</surname><given-names>AL</given-names></name><name><surname>Pressman</surname><given-names>A</given-names></name><name><surname>Ackerson</surname><given-names>L</given-names></name><name><surname>Rudd</surname><given-names>P</given-names></name><name><surname>Neuhaus</surname><given-names>J</given-names></name><name><surname>Vittinghoff</surname><given-names>E</given-names></name></person-group><article-title>Placebo adherence and its association with morbidity and mortality in the studies of left ventricular dysfunction</article-title><source>Journal of general internal medicine</source><year>2010</year><volume>25</volume><issue>12</issue><fpage>1275</fpage><lpage>1281</lpage><pub-id pub-id-type="pmid">20706875</pub-id></element-citation></ref><ref id="R25"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jakicic</surname><given-names>JM</given-names></name><name><surname>Gregg</surname><given-names>E</given-names></name><name><surname>Knowler</surname><given-names>W</given-names></name><name><surname>Kelley</surname><given-names>DE</given-names></name><name><surname>Lang</surname><given-names>W</given-names></name><name><surname>Miller</surname><given-names>GD</given-names></name><etal/></person-group><article-title>Activity patterns of obese adults with type 2 diabetes in the look AHEAD study</article-title><source>Medicine and science in sports and exercise</source><year>2010</year><volume>42</volume><issue>11</issue><fpage>1995</fpage><lpage>2005</lpage><pub-id pub-id-type="pmid">20386337</pub-id></element-citation></ref><ref id="R26"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Unick</surname><given-names>JL</given-names></name><name><surname>Hogan</surname><given-names>PE</given-names></name><name><surname>Neiberg</surname><given-names>RH</given-names></name><name><surname>Cheskin</surname><given-names>LJ</given-names></name><name><surname>Dutton</surname><given-names>GR</given-names></name><name><surname>Evans-Hudnall</surname><given-names>G</given-names></name><etal/></person-group><article-title>Evaluation of early weight loss thresholds for identifying nonresponders to an intensive lifestyle intervention</article-title><source>Obesity (Silver Spring, Md)</source><year>2014</year><volume>22</volume><issue>7</issue><fpage>1608</fpage><lpage>1616</lpage></element-citation></ref><ref id="R27"><label>27</label><element-citation publication-type="journal"><article-title>Effects of weight loss and sodium reduction intervention on blood pressure and hypertension incidence in overweight people with high-normal blood pressure. The Trials of Hypertension Prevention, phase II. The Trials of Hypertension Prevention Collaborative Research Group</article-title><source>Arch Intern Med</source><year>1997</year><volume>157</volume><issue>6</issue><fpage>657</fpage><lpage>667</lpage><pub-id pub-id-type="pmid">9080920</pub-id></element-citation></ref><ref id="R28"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wing</surname><given-names>RR</given-names></name></person-group><article-title>Long-term effects of a lifestyle intervention on weight and cardiovascular risk factors in individuals with type 2 diabetes mellitus: four-year results of the Look AHEAD trial</article-title><source>Arch Intern Med</source><year>2010</year><volume>170</volume><issue>17</issue><fpage>1566</fpage><lpage>1575</lpage><pub-id pub-id-type="pmid">20876408</pub-id></element-citation></ref><ref id="R29"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ensrud</surname><given-names>KE</given-names></name><name><surname>Ewing</surname><given-names>SK</given-names></name><name><surname>Stone</surname><given-names>KL</given-names></name><name><surname>Cauley</surname><given-names>JA</given-names></name><name><surname>Bowman</surname><given-names>PJ</given-names></name><name><surname>Cummings</surname><given-names>SR</given-names></name></person-group><article-title>Intentional and unintentional weight loss increase bone loss and hip fracture risk in older women</article-title><source>J Am Geriatr Soc</source><year>2003</year><volume>51</volume><issue>12</issue><fpage>1740</fpage><lpage>1747</lpage><pub-id pub-id-type="pmid">14687352</pub-id></element-citation></ref><ref id="R30"><label>30</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ensrud</surname><given-names>KE</given-names></name><name><surname>Fullman</surname><given-names>RL</given-names></name><name><surname>Barrett-Connor</surname><given-names>E</given-names></name><name><surname>Cauley</surname><given-names>JA</given-names></name><name><surname>Stefanick</surname><given-names>ML</given-names></name><name><surname>Fink</surname><given-names>HA</given-names></name><etal/></person-group><article-title>Voluntary weight reduction in older men increases hip bone loss: the osteoporotic fractures in men study</article-title><source>J Clin Endocrinol Metab</source><year>2005</year><volume>90</volume><issue>4</issue><fpage>1998</fpage><lpage>2004</lpage><pub-id pub-id-type="pmid">15671096</pub-id></element-citation></ref><ref id="R31"><label>31</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stinton</surname><given-names>LM</given-names></name><name><surname>Myers</surname><given-names>RP</given-names></name><name><surname>Shaffer</surname><given-names>EA</given-names></name></person-group><article-title>Epidemiology of gallstones</article-title><source>Gastroenterology clinics of North America</source><year>2010</year><volume>39</volume><issue>2</issue><fpage>157</fpage><lpage>169</lpage><fpage>vii</fpage><pub-id pub-id-type="pmid">20478480</pub-id></element-citation></ref></ref-list></back><floats-group><table-wrap id="T1" position="float" orientation="landscape"><label>Table 1</label><caption><p id="P91">Comparison of Baseline Characteristics According to Magnitude of First-year Weight Change and Fitness Change in the Overall Look AHEAD Sample.</p></caption><table frame="hsides" rules="none"><tbody><tr><td align="left" rowspan="1" colspan="1"/><td align="center" colspan="5" rowspan="1"><bold>Weight Change Groups (percent weight loss in first year)</bold></td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="center" colspan="5" valign="bottom" rowspan="1"><hr/></td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"><bold>Gain /Stable</bold><break/><bold>(&#x0003c;2% loss)</bold></td><td align="center" rowspan="1" colspan="1"><bold>Small Loss</bold><break/><bold>(2 to 5%)</bold></td><td align="center" rowspan="1" colspan="1"><bold>Medium Loss</bold><break/><bold>(5 to 10%)</bold></td><td align="center" rowspan="1" colspan="1"><bold>Large Loss</bold><break/><bold>(&#x0003e;10%)</bold></td><td align="center" valign="bottom" rowspan="1" colspan="1"><bold>P Value</bold></td></tr><tr><td align="center" colspan="6" valign="bottom" rowspan="1"><hr/></td></tr><tr><td align="left" rowspan="1" colspan="1">N (%)</td><td align="center" rowspan="1" colspan="1">1972 (40.3)</td><td align="center" rowspan="1" colspan="1">914 (18.7)</td><td align="center" rowspan="1" colspan="1">1000 (20.4)</td><td align="center" rowspan="1" colspan="1">1013 (20.7)</td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">ILI Group (%)</td><td align="center" rowspan="1" colspan="1">18.2</td><td align="center" rowspan="1" colspan="1">47.4</td><td align="center" rowspan="1" colspan="1">74.9</td><td align="center" rowspan="1" colspan="1">92.0</td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Men (%)</td><td align="center" rowspan="1" colspan="1">40.5</td><td align="center" rowspan="1" colspan="1">39.2</td><td align="center" rowspan="1" colspan="1">38.7</td><td align="center" rowspan="1" colspan="1">43.9</td><td align="center" rowspan="1" colspan="1">0.07</td></tr><tr><td align="left" rowspan="1" colspan="1">Non-white (%)</td><td align="center" rowspan="1" colspan="1">38.7</td><td align="center" rowspan="1" colspan="1">41.9</td><td align="center" rowspan="1" colspan="1">37.4</td><td align="center" rowspan="1" colspan="1">26.7</td><td align="center" rowspan="1" colspan="1">&#x0003c;0.0001</td></tr><tr><td align="left" rowspan="1" colspan="1">Age (mean years)</td><td align="center" rowspan="1" colspan="1">58.4</td><td align="center" rowspan="1" colspan="1">58.9</td><td align="center" rowspan="1" colspan="1">58.7</td><td align="center" rowspan="1" colspan="1">59.3</td><td align="center" rowspan="1" colspan="1">0.004</td></tr><tr><td align="left" rowspan="1" colspan="1">History of CVD (%)</td><td align="center" rowspan="1" colspan="1">14.3</td><td align="center" rowspan="1" colspan="1">14.0</td><td align="center" rowspan="1" colspan="1">12.2</td><td align="center" rowspan="1" colspan="1">13.8</td><td align="center" rowspan="1" colspan="1">0.46</td></tr><tr><td align="left" rowspan="1" colspan="1">Using Insulin (%)</td><td align="center" rowspan="1" colspan="1">17.9</td><td align="center" rowspan="1" colspan="1">15.7</td><td align="center" rowspan="1" colspan="1">12.9</td><td align="center" rowspan="1" colspan="1">13.9</td><td align="center" rowspan="1" colspan="1">0.002</td></tr><tr><td align="left" rowspan="1" colspan="1">Smoking: Never (%)</td><td align="center" rowspan="1" colspan="1">52.2</td><td align="center" rowspan="1" colspan="1">50.7</td><td align="center" rowspan="1" colspan="1">50.4</td><td align="center" rowspan="1" colspan="1">47.5</td><td align="center" rowspan="1" colspan="1">0.11</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;&#x000a0;Current (%)</td><td align="center" rowspan="1" colspan="1">3.7</td><td align="center" rowspan="1" colspan="1">5.4</td><td align="center" rowspan="1" colspan="1">4.7</td><td align="center" rowspan="1" colspan="1">4.1</td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Duration of Diabetes (mean years)</td><td align="center" rowspan="1" colspan="1">6.8</td><td align="center" rowspan="1" colspan="1">6.9</td><td align="center" rowspan="1" colspan="1">6.6</td><td align="center" rowspan="1" colspan="1">6.8</td><td align="center" rowspan="1" colspan="1">0.45</td></tr><tr><td align="left" rowspan="1" colspan="1">BMI (mean kg/m<sup>2</sup>)</td><td align="center" rowspan="1" colspan="1">35.9</td><td align="center" rowspan="1" colspan="1">35.8</td><td align="center" rowspan="1" colspan="1">35.8</td><td align="center" rowspan="1" colspan="1">36.1</td><td align="center" rowspan="1" colspan="1">0.34</td></tr><tr><td align="left" rowspan="1" colspan="1">LDL Cholesterol (mean mg/DL)</td><td align="center" rowspan="1" colspan="1">112.7</td><td align="center" rowspan="1" colspan="1">113.9</td><td align="center" rowspan="1" colspan="1">110.8</td><td align="center" rowspan="1" colspan="1">110.3</td><td align="center" rowspan="1" colspan="1">0.03</td></tr><tr><td align="left" rowspan="1" colspan="1">SBP (mean mm/Hg)</td><td align="center" rowspan="1" colspan="1">128.6</td><td align="center" rowspan="1" colspan="1">129.7</td><td align="center" rowspan="1" colspan="1">128.7</td><td align="center" rowspan="1" colspan="1">128.4</td><td align="center" rowspan="1" colspan="1">0.12</td></tr><tr><td align="left" rowspan="1" colspan="1">DBP (mean mm/Hg)</td><td align="center" rowspan="1" colspan="1">70.2</td><td align="center" rowspan="1" colspan="1">70.8</td><td align="center" rowspan="1" colspan="1">70.4</td><td align="center" rowspan="1" colspan="1">69.1</td><td align="center" rowspan="1" colspan="1">0.004</td></tr><tr><td align="left" rowspan="1" colspan="1">1-y Change in weight (mean %)</td><td align="center" rowspan="1" colspan="1">1.6</td><td align="center" rowspan="1" colspan="1">&#x02212;3.5</td><td align="center" rowspan="1" colspan="1">&#x02212;7.3</td><td align="center" rowspan="1" colspan="1">&#x02212;15.8</td><td align="center" rowspan="1" colspan="1">NA</td></tr><tr><td align="left" rowspan="1" colspan="1">1-y fitness change (mean METs)</td><td align="center" rowspan="1" colspan="1">0.1</td><td align="center" rowspan="1" colspan="1">0.4</td><td align="center" rowspan="1" colspan="1">0.7</td><td align="center" rowspan="1" colspan="1">1.5</td><td align="center" rowspan="1" colspan="1">&#x0003c;0.0001</td></tr><tr><td align="center" colspan="6" valign="bottom" rowspan="1"><hr/></td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="center" colspan="5" rowspan="1"><bold>Fitness Change Groups (METs change in first-year)</bold></td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="center" colspan="5" valign="bottom" rowspan="1"><hr/></td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"><bold>Loss/Stable</bold><break/><bold>(&#x0003c;0.5)</bold></td><td align="center" rowspan="1" colspan="1"><bold>Small Gain</bold><break/><bold>(0.5 to 1.0)</bold></td><td align="center" rowspan="1" colspan="1"><bold>Medium Gain</bold><break/><bold>(1.0 to 2.0)</bold></td><td align="center" rowspan="1" colspan="1"><bold>Large Gain</bold><break/><bold>(&#x0003e;2.0)</bold></td><td align="center" valign="bottom" rowspan="1" colspan="1"><bold>P Value</bold></td></tr><tr><td align="center" colspan="6" valign="bottom" rowspan="1"><hr/></td></tr><tr><td align="left" rowspan="1" colspan="1">N (%)</td><td align="center" rowspan="1" colspan="1">2306 (52.3)</td><td align="center" rowspan="1" colspan="1">701 (15.9)</td><td align="center" rowspan="1" colspan="1">812 (18.4)</td><td align="center" rowspan="1" colspan="1">591 (13.4)</td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">ILI Group (%)</td><td align="center" rowspan="1" colspan="1">36.9</td><td align="center" rowspan="1" colspan="1">51.5</td><td align="center" rowspan="1" colspan="1">65.6</td><td align="center" rowspan="1" colspan="1">79.4</td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Men (%)</td><td align="center" rowspan="1" colspan="1">37.8</td><td align="center" rowspan="1" colspan="1">38.8</td><td align="center" rowspan="1" colspan="1">43.1</td><td align="center" rowspan="1" colspan="1">52.8</td><td align="center" rowspan="1" colspan="1">&#x0003c;0.0001</td></tr><tr><td align="left" rowspan="1" colspan="1">Non-white (%)</td><td align="center" rowspan="1" colspan="1">38.6</td><td align="center" rowspan="1" colspan="1">36.2</td><td align="center" rowspan="1" colspan="1">31.5</td><td align="center" rowspan="1" colspan="1">30.3</td><td align="center" rowspan="1" colspan="1">&#x0003c;0.0001</td></tr><tr><td align="left" rowspan="1" colspan="1">Age (mean years)</td><td align="center" rowspan="1" colspan="1">59.4</td><td align="center" rowspan="1" colspan="1">58.3</td><td align="center" rowspan="1" colspan="1">58.2</td><td align="center" rowspan="1" colspan="1">57.4</td><td align="center" rowspan="1" colspan="1">&#x0003c;0.0001</td></tr><tr><td align="left" rowspan="1" colspan="1">History of CVD (%)</td><td align="center" rowspan="1" colspan="1">14.6</td><td align="center" rowspan="1" colspan="1">14.3</td><td align="center" rowspan="1" colspan="1">10.7</td><td align="center" rowspan="1" colspan="1">10.8</td><td align="center" rowspan="1" colspan="1">0.008</td></tr><tr><td align="left" rowspan="1" colspan="1">Using Insulin (%)</td><td align="center" rowspan="1" colspan="1">15.4</td><td align="center" rowspan="1" colspan="1">16.3</td><td align="center" rowspan="1" colspan="1">15.8</td><td align="center" rowspan="1" colspan="1">11.2</td><td align="center" rowspan="1" colspan="1">0.05</td></tr><tr><td align="left" rowspan="1" colspan="1">Smoking: Never (%)</td><td align="center" rowspan="1" colspan="1">52.0</td><td align="center" rowspan="1" colspan="1">53.2</td><td align="center" rowspan="1" colspan="1">47.7</td><td align="center" rowspan="1" colspan="1">47.0</td><td align="center" rowspan="1" colspan="1">0.06</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;&#x000a0;Current (%)</td><td align="center" rowspan="1" colspan="1">3.7</td><td align="center" rowspan="1" colspan="1">4.6</td><td align="center" rowspan="1" colspan="1">4.7</td><td align="center" rowspan="1" colspan="1">3.6</td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Duration of Diabetes (mean years)</td><td align="center" rowspan="1" colspan="1">6.8</td><td align="center" rowspan="1" colspan="1">7.0</td><td align="center" rowspan="1" colspan="1">6.4</td><td align="center" rowspan="1" colspan="1">6.4</td><td align="center" rowspan="1" colspan="1">0.18</td></tr><tr><td align="left" rowspan="1" colspan="1">BMI (mean kg/m<sup>2</sup>)</td><td align="center" rowspan="1" colspan="1">35.9</td><td align="center" rowspan="1" colspan="1">36.0</td><td align="center" rowspan="1" colspan="1">36.0</td><td align="center" rowspan="1" colspan="1">34.9</td><td align="center" rowspan="1" colspan="1">0.001</td></tr><tr><td align="left" rowspan="1" colspan="1">LDL Cholesterol (mean mg/DL)</td><td align="center" rowspan="1" colspan="1">112.0</td><td align="center" rowspan="1" colspan="1">112.3</td><td align="center" rowspan="1" colspan="1">112.5</td><td align="center" rowspan="1" colspan="1">110.3</td><td align="center" rowspan="1" colspan="1">0.50</td></tr><tr><td align="left" rowspan="1" colspan="1">SBP (mean mm/Hg)</td><td align="center" rowspan="1" colspan="1">128.7</td><td align="center" rowspan="1" colspan="1">129.4</td><td align="center" rowspan="1" colspan="1">129.1</td><td align="center" rowspan="1" colspan="1">126.4</td><td align="center" rowspan="1" colspan="1">0.01</td></tr><tr><td align="left" rowspan="1" colspan="1">DBP (mean mm/Hg)</td><td align="center" rowspan="1" colspan="1">69.8</td><td align="center" rowspan="1" colspan="1">70.5</td><td align="center" rowspan="1" colspan="1">70.2</td><td align="center" rowspan="1" colspan="1">70.8</td><td align="center" rowspan="1" colspan="1">0.11</td></tr><tr><td align="left" rowspan="1" colspan="1">1-y Change in weight (mean %)</td><td align="center" rowspan="1" colspan="1">&#x02212;2.4</td><td align="center" rowspan="1" colspan="1">&#x02212;5.2</td><td align="center" rowspan="1" colspan="1">&#x02212;7.4</td><td align="center" rowspan="1" colspan="1">&#x02212;11.3</td><td align="center" rowspan="1" colspan="1">&#x0003c;0.0001</td></tr><tr><td align="left" rowspan="1" colspan="1">1-y fitness change (mean METs)</td><td align="center" rowspan="1" colspan="1">&#x02212;0.3</td><td align="center" rowspan="1" colspan="1">0.7</td><td align="center" rowspan="1" colspan="1">1.4</td><td align="center" rowspan="1" colspan="1">2.9</td><td align="center" rowspan="1" colspan="1">NA</td></tr></tbody></table><table-wrap-foot><fn id="TFN1"><label>*</label><p id="P92">P-values obtained using the Kruskal-Wallis test for continuous variables and Chi-square test for categorical variables.</p></fn></table-wrap-foot></table-wrap><table-wrap id="T2" position="float" orientation="landscape"><label>Table 2</label><caption><p id="P93">Primary and Secondary Outcomes Associated with Percent Weight Change and Fitness Change: Overall Sample (ILI and DSE Combined)</p></caption><table frame="hsides" rules="cols"><tbody><tr><td align="left" rowspan="1" colspan="1"/><td align="center" colspan="4" rowspan="1"><bold>Weight Change Groups (percent weight loss in first year)</bold></td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="center" colspan="6" valign="bottom" rowspan="1"><hr/></td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"><bold>Gain /Stable</bold><break/><bold>(&#x0003c;2% loss)</bold></td><td align="center" rowspan="1" colspan="1"><bold>Small Loss</bold><break/><bold>(2 to 5%)</bold></td><td align="center" rowspan="1" colspan="1"><bold>Medium Loss</bold><break/><bold>(5 to 10%)</bold></td><td align="center" rowspan="1" colspan="1"><bold>Large Loss</bold><break/><bold>(&#x02265;10%)</bold></td><td align="center" valign="top" rowspan="1" colspan="1"><bold>Test for Trend</bold></td></tr><tr><td align="center" colspan="6" valign="bottom" rowspan="1"><hr/></td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Primary Outcome</bold></td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Events / person years</td><td align="center" rowspan="1" colspan="1">289 / 17075</td><td align="center" rowspan="1" colspan="1">141 / 7870</td><td align="center" rowspan="1" colspan="1">154 / 8570</td><td align="center" rowspan="1" colspan="1">128 / 8942</td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Crude rate/100 person years</td><td align="center" rowspan="1" colspan="1">1.69</td><td align="center" rowspan="1" colspan="1">1.79</td><td align="center" rowspan="1" colspan="1">1.80</td><td align="center" rowspan="1" colspan="1">1.43</td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Unadjusted HR (95% C.I.)</td><td align="center" rowspan="1" colspan="1">1.0</td><td align="center" rowspan="1" colspan="1">1.07 (0.88 &#x02013; 1.31)</td><td align="center" rowspan="1" colspan="1">1.07 (0.88 &#x02013; 1.31)</td><td align="center" rowspan="1" colspan="1">0.83 (0.67&#x02013;1.02)</td><td align="center" rowspan="1" colspan="1">0.21</td></tr><tr><td align="left" rowspan="1" colspan="1">Adjusted HR <xref ref-type="table-fn" rid="TFN2">&#x001c2;</xref> (95% C.I.)</td><td align="center" rowspan="1" colspan="1">1.0</td><td align="center" rowspan="1" colspan="1">1.08 (0.88 &#x02013; 1.33)</td><td align="center" rowspan="1" colspan="1">1.16 (0.95 &#x02013; 1.42)</td><td align="center" rowspan="1" colspan="1">0.79 (0.64&#x02013;0.98)<xref ref-type="table-fn" rid="TFN3">*</xref></td><td align="center" rowspan="1" colspan="1">0.17</td></tr><tr><td align="center" colspan="6" valign="bottom" rowspan="1"><hr/></td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Secondary Outcome</bold></td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Events / person years</td><td align="center" rowspan="1" colspan="1">422 / 16699</td><td align="center" rowspan="1" colspan="1">206 / 7657</td><td align="center" rowspan="1" colspan="1">203 / 8411</td><td align="center" rowspan="1" colspan="1">186 / 8792</td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Crude rate/100 person years</td><td align="center" rowspan="1" colspan="1">2.53</td><td align="center" rowspan="1" colspan="1">2.69</td><td align="center" rowspan="1" colspan="1">2.41</td><td align="center" rowspan="1" colspan="1">2.12</td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Unadjusted HR (95% C.I.)</td><td align="center" rowspan="1" colspan="1">1.0</td><td align="center" rowspan="1" colspan="1">1.08 (0.91&#x02013; 1.27)</td><td align="center" rowspan="1" colspan="1">0.96(0.81&#x02013; 1.13)</td><td align="center" rowspan="1" colspan="1">0.83 (0.70 &#x02013; 0.99)<xref ref-type="table-fn" rid="TFN3">*</xref></td><td align="center" rowspan="1" colspan="1">0.04</td></tr><tr><td align="left" rowspan="1" colspan="1">Adjusted HR <xref ref-type="table-fn" rid="TFN2">&#x001c2;</xref> (95% C.I.)</td><td align="center" rowspan="1" colspan="1">1.0</td><td align="center" rowspan="1" colspan="1">1.05 (0.88 &#x02013; 1.25)</td><td align="center" rowspan="1" colspan="1">0.97 (0.82 &#x02013; 1.16)</td><td align="center" rowspan="1" colspan="1">0.76 (0.63 &#x02013; 0.91)<xref ref-type="table-fn" rid="TFN3">*</xref></td><td align="center" rowspan="1" colspan="1">0.006</td></tr><tr><td align="center" colspan="6" valign="bottom" rowspan="1"><hr/></td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="center" colspan="4" rowspan="1"><bold>Fitness Change Groups (METs change in first-year)</bold></td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="center" colspan="6" valign="bottom" rowspan="1"><hr/></td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"><bold>Loss/Stable</bold><break/><bold>(&#x0003c;0.5)</bold></td><td align="center" rowspan="1" colspan="1"><bold>Small Gain</bold><break/><bold>(0.5 to 1.0)</bold></td><td align="center" rowspan="1" colspan="1"><bold>Medium Gain</bold><break/><bold>(1.0 to 2.0)</bold></td><td align="center" rowspan="1" colspan="1"><bold>Large Gain</bold><break/><bold>(&#x02265;2.0)</bold></td><td align="center" valign="top" rowspan="1" colspan="1"><bold>Test for Trend</bold></td></tr><tr><td align="center" colspan="6" valign="bottom" rowspan="1"><hr/></td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Primary Outcome</bold></td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Events / person years</td><td align="center" rowspan="1" colspan="1">347 / 19997</td><td align="center" rowspan="1" colspan="1">95 / 6091</td><td align="center" rowspan="1" colspan="1">102 / 7183</td><td align="center" rowspan="1" colspan="1">72 / 5312</td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Crude rate/100 person years</td><td align="center" rowspan="1" colspan="1">1.74</td><td align="center" rowspan="1" colspan="1">1.56</td><td align="center" rowspan="1" colspan="1">1.42</td><td align="center" rowspan="1" colspan="1">1.36</td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Unadjusted HR (95% C.I.)</td><td align="center" rowspan="1" colspan="1">1.0</td><td align="center" rowspan="1" colspan="1">0.88 (0.70 &#x02013; 1.10)</td><td align="center" rowspan="1" colspan="1">0.80 (0.64 &#x02013; 1.00)</td><td align="center" rowspan="1" colspan="1">0.76 (0.59 &#x02013; 0.98)<xref ref-type="table-fn" rid="TFN3">*</xref></td><td align="center" rowspan="1" colspan="1">0.009</td></tr><tr><td align="left" rowspan="1" colspan="1">Adjusted HR <xref ref-type="table-fn" rid="TFN2">&#x001c2;</xref> (95% C.I.)</td><td align="center" rowspan="1" colspan="1">1.0</td><td align="center" rowspan="1" colspan="1">0.87 (0.68 &#x02013; 1.10)</td><td align="center" rowspan="1" colspan="1">0.83 (0.66 &#x02013; 1.05)</td><td align="center" rowspan="1" colspan="1">0.78 (0.60 &#x02013; 1.03)</td><td align="center" rowspan="1" colspan="1">0.03</td></tr><tr><td align="center" colspan="6" valign="bottom" rowspan="1"><hr/></td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Secondary Outcome</bold></td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Events / person years</td><td align="center" rowspan="1" colspan="1">504 / 19596</td><td align="center" rowspan="1" colspan="1">131 / 5996</td><td align="center" rowspan="1" colspan="1">145 / 7056</td><td align="center" rowspan="1" colspan="1">100 / 5220</td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Crude rate/100 person years</td><td align="center" rowspan="1" colspan="1">2.57</td><td align="center" rowspan="1" colspan="1">2.18</td><td align="center" rowspan="1" colspan="1">2.05</td><td align="center" rowspan="1" colspan="1">1.92</td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Unadjusted HR (95% C.I.)</td><td align="center" rowspan="1" colspan="1">1.0</td><td align="center" rowspan="1" colspan="1">0.83 (0.69 &#x02013; 1.01)</td><td align="center" rowspan="1" colspan="1">0.79 (0.65 &#x02013; 0.95)<xref ref-type="table-fn" rid="TFN3">*</xref></td><td align="center" rowspan="1" colspan="1">0.73 (0.59 &#x02013; 0.91)<xref ref-type="table-fn" rid="TFN3">*</xref></td><td align="center" rowspan="1" colspan="1">0.0005</td></tr><tr><td align="left" rowspan="1" colspan="1">Adjusted HR <xref ref-type="table-fn" rid="TFN2">&#x001c2;</xref> (95% C.I.)</td><td align="center" rowspan="1" colspan="1">1.0</td><td align="center" rowspan="1" colspan="1">0.84 (0.69 &#x02013; 1.02)</td><td align="center" rowspan="1" colspan="1">0.79 (0.65 &#x02013; 0.96)<xref ref-type="table-fn" rid="TFN3">*</xref></td><td align="center" rowspan="1" colspan="1">0.77 (0.61 &#x02013; 0.96)<xref ref-type="table-fn" rid="TFN3">*</xref></td><td align="center" rowspan="1" colspan="1">0.0031</td></tr></tbody></table><table-wrap-foot><fn id="TFN2"><label>&#x001c2;</label><p id="P94">adjusted for sex, age, baseline weight (weight change models), baseline fitness (fitness change models),CVD history, insulin use, diabetes duration, smoking status, LDL, SBP, DBP. Primary Outcome: (non-fatal MI, stroke, hospitalized angina, CVD death); Secondary Outcome: (non-fatal MI, stroke, hospitalized angina, CABG/PTCA, hospitalized CHF, carotid endarterectomy, PVD, total mortality);</p></fn><fn id="TFN3"><label>*</label><p id="P95">P&#x0003c; 0.05</p></fn></table-wrap-foot></table-wrap><table-wrap id="T3" position="float" orientation="landscape"><label>Table 3</label><caption><p id="P96">Primary and Secondary Outcomes Associated with Percent Weight Loss and Fitness Change over the First Year: Comparison of DSE Condition (Referent Group) with ILI weight loss and fitness change groups.</p></caption><table frame="hsides" rules="none"><tbody><tr><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" colspan="4" rowspan="1"><bold>ILI Weight Change Groups (percent weight loss in first year)</bold></td><td align="center" colspan="2" rowspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" colspan="6" valign="bottom" rowspan="1"><hr/></td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"><bold>Overall</bold><break/><bold>DSE</bold></td><td align="center" rowspan="1" colspan="1"><bold>Gain /Stable</bold><break/><bold>(&#x0003c;2% loss)</bold></td><td align="center" rowspan="1" colspan="1"><bold>Small Loss</bold><break/><bold>(2 to 5%)</bold></td><td align="center" rowspan="1" colspan="1"><bold>Medium Loss</bold><break/><bold>(5 to 10%)</bold></td><td align="center" rowspan="1" colspan="1"><bold>Large Loss</bold><break/><bold>(&#x0003e;10%)</bold></td><td align="center" rowspan="1" colspan="1"><bold>HR per SD weight</bold><break/><bold>change</bold></td><td align="center" valign="top" rowspan="1" colspan="1"><bold>P value</bold></td></tr><tr><td align="center" colspan="8" valign="bottom" rowspan="1"><hr/></td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Primary Outcome</bold></td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Events / person years</td><td align="center" rowspan="1" colspan="1">351 / 20891</td><td align="center" rowspan="1" colspan="1">58 / 3087</td><td align="center" rowspan="1" colspan="1">69 / 3766</td><td align="center" rowspan="1" colspan="1">114 / 6446</td><td align="center" rowspan="1" colspan="1">120 / 8266</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Crude rate/100 person years</td><td align="center" rowspan="1" colspan="1">1.68</td><td align="center" rowspan="1" colspan="1">1.88</td><td align="center" rowspan="1" colspan="1">1.83</td><td align="center" rowspan="1" colspan="1">1.77</td><td align="center" rowspan="1" colspan="1">1.45</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Unadjusted HR (95% C.I.)</td><td align="center" rowspan="1" colspan="1">1.0</td><td align="center" rowspan="1" colspan="1">1.14 (0.86&#x02013; 1.51)</td><td align="center" rowspan="1" colspan="1">1.09 (0.85 &#x02013; 1.42)</td><td align="center" rowspan="1" colspan="1">1.06 (0.86 &#x02013; 1.31)</td><td align="center" rowspan="1" colspan="1">0.84 (0.68 &#x02013; 1.04)</td><td align="center" rowspan="1" colspan="1">0.88 (0.79 &#x02013; 0.98)</td><td align="center" rowspan="1" colspan="1">0.02</td></tr><tr><td align="left" rowspan="1" colspan="1">Adjusted HR <xref ref-type="table-fn" rid="TFN4">&#x001c2;</xref> (95% C.I.)</td><td align="center" rowspan="1" colspan="1">1.0</td><td align="center" rowspan="1" colspan="1">1.29 (0.96 &#x02013; 1.72)</td><td align="center" rowspan="1" colspan="1">1.04 (0.80 &#x02013; 1.36)</td><td align="center" rowspan="1" colspan="1">1.15 (0.92 &#x02013; 1.43)</td><td align="center" rowspan="1" colspan="1">0.80 (0.65 &#x02013; 0.99)*</td><td align="center" rowspan="1" colspan="1">0.85 (0.76 &#x02013; 0.95)</td><td align="center" rowspan="1" colspan="1">0.006</td></tr><tr><td align="center" colspan="6" valign="bottom" rowspan="1"><hr/></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Secondary Outcome</bold></td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Events / person years</td><td align="center" rowspan="1" colspan="1">503 / 20436</td><td align="center" rowspan="1" colspan="1">82 / 3009</td><td align="center" rowspan="1" colspan="1">108 / 3643</td><td align="center" rowspan="1" colspan="1">151 / 6335</td><td align="center" rowspan="1" colspan="1">173 / 8136</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Crude rate/100 person years</td><td align="center" rowspan="1" colspan="1">2.46</td><td align="center" rowspan="1" colspan="1">2.72</td><td align="center" rowspan="1" colspan="1">2.96</td><td align="center" rowspan="1" colspan="1">2.38</td><td align="center" rowspan="1" colspan="1">2.13</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Unadjusted HR (95% C.I.)</td><td align="center" rowspan="1" colspan="1">1.0</td><td align="center" rowspan="1" colspan="1">1.14 (0.90 &#x02013; 1.44)</td><td align="center" rowspan="1" colspan="1">1.22 (0.99 &#x02013; 1.50)</td><td align="center" rowspan="1" colspan="1">0.97 (0.81 &#x02013; 1.17)</td><td align="center" rowspan="1" colspan="1">0.85 (0.72 &#x02013;1.02)</td><td align="center" rowspan="1" colspan="1">0.86 (0.78 &#x02013; 0.94)</td><td align="center" rowspan="1" colspan="1">0.0007</td></tr><tr><td align="left" rowspan="1" colspan="1">Adjusted HR <xref ref-type="table-fn" rid="TFN4">&#x001c2;</xref> (95% C.I.)</td><td align="center" rowspan="1" colspan="1">1.0</td><td align="center" rowspan="1" colspan="1">1.28 (1.01 &#x02013; 1.64)*</td><td align="center" rowspan="1" colspan="1">1.19 (0.96 &#x02013; 1.47)</td><td align="center" rowspan="1" colspan="1">1.02 (0.84 &#x02013; 1.23)</td><td align="center" rowspan="1" colspan="1">0.79 (0.66 &#x02013; 0.95)*</td><td align="center" rowspan="1" colspan="1">0.82 (0.74 &#x02013; 0.90)</td><td align="center" rowspan="1" colspan="1">&#x0003c;0.0001</td></tr><tr><td align="center" colspan="8" valign="bottom" rowspan="1"><hr/></td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" colspan="4" rowspan="1"><bold>ILI Fitness Change Groups (METs change in first-year)</bold></td><td align="center" colspan="2" rowspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" colspan="6" valign="bottom" rowspan="1"><hr/></td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"><bold>Overall</bold><break/><bold>DSE</bold></td><td align="center" rowspan="1" colspan="1"><bold>Loss/Stable</bold><break/><bold>(&#x0003c;0.5)</bold></td><td align="center" rowspan="1" colspan="1"><bold>Small Gain</bold><break/><bold>(0.5 to 1.0)</bold></td><td align="center" rowspan="1" colspan="1"><bold>Medium Gain</bold><break/><bold>(1.0 to 2.0)</bold></td><td align="center" rowspan="1" colspan="1"><bold>Large Gain</bold><break/><bold>(&#x0003e;2.0)</bold></td><td align="center" rowspan="1" colspan="1"><bold>HR per SD fitness</bold><break/><bold>change</bold></td><td align="center" valign="top" rowspan="1" colspan="1"><bold>P value</bold></td></tr><tr><td align="center" colspan="8" valign="bottom" rowspan="1"><hr/></td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Primary Outcome</bold></td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Events / person years</td><td align="center" rowspan="1" colspan="1">303 / 19025</td><td align="center" rowspan="1" colspan="1">148 / 8025</td><td align="center" rowspan="1" colspan="1">53 / 3081</td><td align="center" rowspan="1" colspan="1">64 / 4743</td><td align="center" rowspan="1" colspan="1">59 / 4190</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Crude rate/100 person years</td><td align="center" rowspan="1" colspan="1">1.59</td><td align="center" rowspan="1" colspan="1">1.84</td><td align="center" rowspan="1" colspan="1">1.72</td><td align="center" rowspan="1" colspan="1">1.35</td><td align="center" rowspan="1" colspan="1">1.41</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Unadjusted HR (95% C.I.)</td><td align="center" rowspan="1" colspan="1">1.0</td><td align="center" rowspan="1" colspan="1">1.18 (0.97 &#x02013; 1.43)</td><td align="center" rowspan="1" colspan="1">1.06 (0.79 &#x02013; 1.42)</td><td align="center" rowspan="1" colspan="1">0.84 (0.64 &#x02013; 1.10)</td><td align="center" rowspan="1" colspan="1">0.87 (0.66 &#x02013; 1.15)</td><td align="center" rowspan="1" colspan="1">0.90(0.80 &#x02013;1.01)</td><td align="center" rowspan="1" colspan="1">0.08</td></tr><tr><td align="left" rowspan="1" colspan="1">Adjusted HR <xref ref-type="table-fn" rid="TFN4">&#x001c2;</xref> (95% C.I.)</td><td align="center" rowspan="1" colspan="1">1.0</td><td align="center" rowspan="1" colspan="1">1.19 (0.97 &#x02013; 1.46)</td><td align="center" rowspan="1" colspan="1">1.06 (0.78 &#x02013; 1.43)</td><td align="center" rowspan="1" colspan="1">0.85 (0.64 &#x02013; 1.13)</td><td align="center" rowspan="1" colspan="1">0.90 (0.68 &#x02013; 1.21)</td><td align="center" rowspan="1" colspan="1">0.91(0.80 &#x02013; 1.03)</td><td align="center" rowspan="1" colspan="1">0.15</td></tr><tr><td align="center" colspan="8" valign="bottom" rowspan="1"><hr/></td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Secondary Outcome</bold></td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Events / person years</td><td align="center" rowspan="1" colspan="1">433 / 18657</td><td align="center" rowspan="1" colspan="1">211 / 7844</td><td align="center" rowspan="1" colspan="1">78 / 3041</td><td align="center" rowspan="1" colspan="1">92 / 4663</td><td align="center" rowspan="1" colspan="1">86 / 4111</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Crude rate/100 person years</td><td align="center" rowspan="1" colspan="1">2.32</td><td align="center" rowspan="1" colspan="1">2.69</td><td align="center" rowspan="1" colspan="1">2.57</td><td align="center" rowspan="1" colspan="1">1.97</td><td align="center" rowspan="1" colspan="1">2.09</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Unadjusted HR (95% C.I.)</td><td align="center" rowspan="1" colspan="1">1.0</td><td align="center" rowspan="1" colspan="1">1.18 (1.00 &#x02013; 1.39)*</td><td align="center" rowspan="1" colspan="1">1.09 (0.86 &#x02013; 1.39)</td><td align="center" rowspan="1" colspan="1">0.85(0.68 &#x02013; 1.06)</td><td align="center" rowspan="1" colspan="1">0.90 (0.71 &#x02013; ;1.13)</td><td align="center" rowspan="1" colspan="1">0.91 (0.83 &#x02013; 1.01)</td><td align="center" rowspan="1" colspan="1">0.07</td></tr><tr><td align="left" rowspan="1" colspan="1">Adjusted HR <xref ref-type="table-fn" rid="TFN4">&#x001c2;</xref> (95% C.I.)</td><td align="center" rowspan="1" colspan="1">1.0</td><td align="center" rowspan="1" colspan="1">1.17 (0.99 &#x02013; 1.39)</td><td align="center" rowspan="1" colspan="1">1.08 (0.84 &#x02013; 1.38)</td><td align="center" rowspan="1" colspan="1">0.83 (0.66 &#x02013; 1.05)</td><td align="center" rowspan="1" colspan="1">0.93 (0.73 &#x02013; 1.18)</td><td align="center" rowspan="1" colspan="1">0.92 (0.83 &#x02013; 1.02)</td><td align="center" rowspan="1" colspan="1">0.12</td></tr></tbody></table><table-wrap-foot><fn id="TFN4"><label>&#x001c2;</label><p id="P97">adjusted for sex, age, baseline weight (weight change models), baseline fitness (fitness change models), CVD history, insulin use, diabetes duration, smoking status, LDL, SBP, DBP. Primary Outcome: (non-fatal MI, stroke, hospitalized angina, CVD death); Secondary Outcome: (non-fatal MI, stroke, hospitalized angina, CABG/PTCA, hospitalized CHF, carotid endarterectomy, PVD, total mortality).</p></fn></table-wrap-foot></table-wrap><boxed-text id="BX1" position="float" orientation="portrait"><caption><title>Research in context</title></caption><sec id="S17"><title>Evidence before this study</title><p id="P98">Randomized controlled trials (RCTs) have shown that lifestyle interventions lead to diverse benefits among persons with diabetes, improved glycemic control (<xref rid="R4" ref-type="bibr">4</xref>&#x02013;<xref rid="R9" ref-type="bibr">9</xref>) but the Look AHEAD Study found no significant effect on CVD morbidity and mortality (<xref rid="R9" ref-type="bibr">9</xref>, <xref rid="R11" ref-type="bibr">11</xref>&#x02013;<xref rid="R13" ref-type="bibr">13</xref>). It remains unclear, however, whether the impact of the intervention depends upon the magnitude of weight loss, fitness change, or response to the intervention. Authors searched PubMed for randomized controlled trials and quasi-experimental studies from 1990 to 2016 as background data.</p></sec><sec id="S18"><title>Added value of this study</title><p id="P99">These secondary analyses of the Look AHEAD study found that achievement of a 10% weight loss or a 2 MET fitness increase in the first year was associated with an approximate 20% reduced CVD risk while there was no association of small or moderate weight loss with CVD risk. Analyses comparing ILI participants who met the 10% weight loss goal to the full group of DSE participants yielded a similar reduction in CVD incidence. These analyses suggest that greater magnitude of weight loss was associated with lower CVD incidence, and that Look AHEAD did not achieve a large enough weight loss or fitness change among enough people to affect CVD incidence.</p></sec><sec id="S19"><title>Implications of all the available evidence</title><p id="P100">These findings, combined with evidence for reduced incidence of diabetes, hypertension, disability, and other benefits indicate a need to continue to refine approaches to identify participants most likely to benefit from lifestyle interventions, and to develop strategies to improve the magnitude of sustained weight loss to lifestyle interventions.</p></sec></boxed-text></floats-group></article>